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INTRODUCTION 
  -  
 
 
INTRODUCTION: 
           
                              Infections    have   been   one   of   the   major   causes   of  
 
morbidity   and   mortality  worldwide   among  human   population[49].    All      
 
microorganisms  namely Bacteria, Viruses,Parasites and Fungi cause  variety  
 
of    infections    affecting   every  organ   system  of  the  body.   Respiratory    
 
infections, Gastrointestinal,Central nervous system[54],  Skin  and  Soft tissue   
 
infections  are  some  of  them   to  be  mentioned.   Staphylococcus  aureus ,   
 
one   of   the   earliest  detected  bacteria   was  discovered  by  Sir Alexander  
 
Ogston  in1880 in Aberdeen, Scotland[22].S.aureus is responsible  for  a  wide  
 
range  of   infections  most  notable  among   which   are  Neonatal  sepsis[85],  
 
Endocarditis[133] ,   Bacteremia[31],     and   Skin   infections.  S.aureus   is   an    
 
important   pathogen  causing   serious   infections   both   in   hospitals   and   
 
Community.  
 
                                    Discovery  of    antimicrobial   agents   is  one  of   the    
 
most   important  developments  in  modern  medicine.  The   modern  era  of  
 
chemotherapy   began   in   1935   after   the   discovery  of    Sulphonamides   
 
by   German    chemist   Gerhard  Domagk [39]    which    was    marketed   by    
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Bayer    by   the    trade    name    Prontosil.  Sulphonamides  were   used  for   
 
treating   Staphylococcal   septicemia,  puerperal sepsis  and  Meningococcal   
 
infections    successfully.  This   was  followed  by   the  discovery  of  newer  
 
therapeutic agents by  many   people   which  contributed   to  the  Antibiotic    
 
revolution   in  the  last  century. Penicillin   was  discovered  by   Alexander  
 
Fleming    in   1928[128]    and   it   was   therapeutically    used    by   Howard   
 
Flory   in  1940.  Initially   penicillin  was  used   for  the   treatment   of  war  
 
Wounds   in  1943.  Streptomycin   was     discovered     by     an    American   
 
Microbiologist   Selman  Walksman [19]   in   1943.   In  1948  Cephalosporin    
 
was    identified    by   Brotzu [40]    and     introduced    for   therapeutic    use    
 
in   1964.    This      was   followed     by   the   discovery   of   Erythromycin     
 
by    Mc Guire[41]  in   1952,   Tetracycline   by   Lioyd Conover[74]  in  1955,  
 
Rifamycin   by  Sensi and  Margalith [42] in 1957,  Vancomycin  by  Edmund  
 
Kornfeld   in   1958[18] , the   first  Quinolone,  Nalidixic   acid    by    George   
 
Lesher[131]    in   1962,   Minocycline    in    1967[74] Tegicycline   in  1990[74],   
 
Linezolid  by E.I.Dupont  de  Nemours[77]  in  2000,  Daptomycin in 2003[76],    
 
Telithromycin   in  2004[75]   and  a  newer  anti  tuberculous  drug   TMC207    
 
by    Andries[43]   et al   in  2005.  Within   a   very  short   period  after     it’s     
 
discovery   (1943),   resistance   to  Penicillin    was    developed    by   many    
 
microorganisms,  Staphylococcus aureus   being   the   earliest. 
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ANTIMICROBIAL RESISTANCE: 
   
                  Microbial  resistance  to Antimicrobial agents can be  Intrinsic  or  
 
Extrinsic[8]. Intrinsic  resistance  results  from  the  normal  genetic  structure  
 
or   Physiological    state   of    the   micro organism.  Extrinsic  resistance  is  
 
defined    as    the    acquired    ability    of   a   pathogen    to    withstand   an   
 
antibiotic    that    kills   off   it’s   sensitive   counterparts.  During   the   past   
 
twenty   five   years,  alarming  number  of  bacterial   strains  have   evolved   
 
with   resistance   to   antimicrobial    agents[79].   This    resistant    microbial     
 
strains   have    become   one   of    the   major  concerns   of   the  Clinicians,   
 
Microbiologists  and  Public  Health officials.  Resistance   to   antimicrobial   
 
agents   developed  by    micro organisms  has  created  a  major  problem  in   
 
the   treatment   of   not  only  serious  and   life    threatening   infections   in     
 
Hospitals     but    also     common    infections    at   the   Community   level.   
.    
Those  patients  who  are  in  the  intensive  care  units and  burns wards  and      
 
 infants   and  elderly  are   particularly   vulnerable[20] .                                                                                         
 
                                    Widespread  misuse  of   antimicrobial  agents  is  one    
 
of    the   important    factors   for   favouring   the   emergence   of   resistant    
 
bacterial   strains.   Genetic  variability   is  essential  for the  development of  
 
microbial  resistance   which   occurs  through  various  mechanisms such  as     
 
1.Point mutation  occurring  in  nucleoside  base pair  resulting  in  alteration  
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of  enzyme  substrate or the  target site of  antimicrobial  agents.2.Largescale  
 
rearrangements of the bacterial genome generated by Integrons, Transposons   
 
or   Insertion   sequences.   3. Acquisition   of   foreign  DNA   by   plasmids,   
 
bacteriophages  or  transposable    genetic  elements[71]  This   inheritance  of  
 
foreign   DNA   contributes   to   organism’s   genetic   variability    and   it’s   
 
capacity   to    respond     to   the    selection    pressures    imposed    by   the  
 
antimicrobial   agents. Resistance  to antimicrobial  agents  is  also  mediated  
 
by   microbial   enzymes   such   as   Beta lactamase    which   inactivate   the  
 
therapeutic  agents.        
                                         
                               Methicillin, a betalactam antibiotic  variant  of  penicillin     
 
class    (2,6-  dimethoxy phenyl penicillin)    was   introduced    in   1959   by    
 
Beecham[27].It  was  used   to  treat   infections  caused   by   resistant  strains   
 
of  S.aureus,  but  because  of  it’s  toxicity such  as aplastic anaemia [50]  and    
 
nephrotoxicity[73], Methicillin  is  no  longer   used   for  therapeutic  purpose  
 
nowadays.  Very   soon   after    it’s   discovery,    Methcillin   Resistance   to   
 
S.aureus  (MRSA)  was   identified   in  1961[122]  and   has  been   increasing   
 
since  that  time. 
                                         
                            Methicillin   resistance  first  appeared  among  nosocomial  
 
isolates   of   S.aureus    in  England   in   1961. Prevalence    of    MRSA   in   
 
hospital   infections   in   England  was   21%  in 1975  which   became  35%   
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in   1991[13] . Now   it   is   prevalent   world wide   and   varies   from   place     
 
to    place    ranging    from     2%  to 70%    except   a    few   countries   like   
 
Netherland  where   the   prevalence  of   MRSA is <0.5% [127]. In  India,  the    
 
prevalence    of   MRSA   is   estimated   to  be  30  to 70   percent[7] .   Since    
 
MRSA    strain  can    resist   practically    all    available   antibiotics,  it  has   
 
risen    to    the   level   of   public   health   threat  in   hospitals   and   in  the    
 
community  eversince   it’s  identification.  Health  care  Associated   MRSA     
 
(HA- MRSA)     is     different     from      Community     Acquired     MRSA      
 
(CA- MRSA )    in    epidemiological   and   molecular  aspects.   Methicillin       
 
resistance   in  S.aureus   is   mediated   by   mec A  gene   which   codes  for     
 
a   modified  penicillin  binding   protein  2a [72]  (PBP -2a). This    resistance     
 
can   be    constitutive   or   inducible.  Mec A   gene   is   carried  on  mobile    
 
genetic    elements,   Staphylococcal   Cassette  Chromosome [27] (SCC mec).   
 
Atleast   five   different   SCC mec   types   of    varying    genetic  sequences   
 
and   size   have   been   described.   Types  1 to 3  are  found   in   healthcare   
 
associated     MRSA   strains   and     tend    to   be    larger   and    multidrug  
 
resistant.  Types  4 and 5    are    associated    with    community    associated     
 
MRSA    and   are   smaller  and   more     susceptible   to   antibiotics   other     
 
than    Betalactam    antibiotics. CA- MRSA    also    carries   the   gene    for    
 
Panton   Valentine   Leucocidin   along   with   SCC   mec  type IV  element.  
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P.V.L     is   a   virulent    factor    which   was   described    by   Panton   and  
 
Valentine [79]   in   1932.  The   genes  coding   for  PVL   are  luk S-PV   and    
 
luk F-PV.  PVL +ve    CA- MRSA   strains   are    associated   with     severe     
 
necrotising     pneumonia    with    very     high   fatal    outcome.         
 
                          Hospital  acquired   MRSA    is  commonly  associated  with   
 
pneumonia  and   bacteremia.   MRSA    bacteremia   is  a  serious  condition    
 
which  carries the  risk of  fatality  ranging  from  23%  to  54%.  HA-MRSA    
 
is   commonly  found  among   infants  and  elderly  and   presents  with  risk    
 
factors     such     as     longer    hospital   stay [121],   urinary   catheterization,  
 
Diabetes,  prior  antibiotics  especially  quinolones,  acute   renal   failure [16]. 
                                          
                       CA  MRSA  infection   is   usually   associated   with   various   
 
risk   factors  such  as  weak  immune  system  (as  in  HIVinfection,  cancer,  
 
asthma, I.V drug abuse)    and      prolonged    exposure    to   antibiotics [118].  
 
People     who    spend    time   in   confined    places    such   as   prisons [80],  
 
military   barracks[134],  college  students   who  live   in dormitories,   people     
 
who    spend    time   in   coastal   areas   where   MRSA   is  present, athletes    
 
and    football   players,   people    who   are  rearing   livestock  animals  that   
 
are    infected    by   CA- MRSA    are   also   at   risk   of    getting   infected   
 
with       MRSA.    It       produces      primarily      skin     and    soft     tissue  
 
infections[92]. Recently  it   has   been  found   to  be    associated   with   fatal   
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necrotizing    pneumonia,  necrotizing   fasciitis [10 ],  Meningitis   and   Brain   
 
abscess [104],  Bone   and    joints   infections.  A newer  strain of CA- MRSA  
 
USA  300  was  identified   in  2001.    Now     it’s    prevalence     has   been    
 
documented     worldwide [60].  This   new   Strain    has    caused    infections     
 
in    players [11]   and    military   recruits.  CA- MRSA  USA 300   has   been      
 
reported    to     have     caused     nosocomial   infections [91]   also   such   as    
 
bacteremia [106]    and    osteomyelitis [38]    and   prosthetic   joint   infections. 
 
                                           
                                            Drug   resistance    in   other    bacteria   such   as  
 
Neisseria gonorrhoeae,  Salmonella , Shigella,   Mycobacterium tuberculosis  
 
and  Streptococcus  pneumoniae   is  mainly  community   acquired  problem   
 
whereas  MRSA  were  identified  as nosocomial pathogens [122].Commonest  
 
site   of  carriage  of   MRSA   is  anterior  nares [2]  MRSA   is    resistant   to   
 
many   antibiotics   and  it  is  very  difficult  to  eradicate   from   patients  as  
 
well  as  carriers. The  therapeutic options are  limited  and  the  spectrum  of   
 
resistance   is  worrying.  The glycopeptide  antibiotic  Vancomycin [115]  and    
 
the   lipopeptide    antibiotic    Daptomycin [15]    are   used   to  treat    severe    
 
MRSA     infections.    Unfortunately    MRSA    strains    resistant   to  these   
 
drugs  have started  emerging  recently [47].   
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DETECTION OF METHICILLIN RESISTANCE 
 
                                           The     early     and    accurate   determination    of    
 
Methicillin   resistance    is    of    key   importance   in    the     treatment   of     
 
infections   caused    by   Methicillin    resistant    S.aureus   and    prevention     
 
of     MRSA    carriage.   Various     methods     are     available [14]    for   the    
 
detection    of   MRSA    namely    determination   of  Minimum    Inhibitory    
 
Concentration   (M.I.C)  of   Methicillin    by   Broth   macrodilution,   Broth    
 
microdilution,     Agar   dilution   methods    and    Epsilometry   (E.Test) [63].  
 
Other     methods     of     MRSA     detection     include    use     of     various   
 
chromogenic    media   such   as    CHROM agar [62],    MRSA   Select   agar,    
 
MRSA ID    media [124] and    Oxacillin  Resistance  Screening   Agar    Base    
 
(ORSAB) [3] ,      Latex   agglutination,      which     is    a     rapid      method    
 
of    detecting    PBP2a [125]    and   Molecular     methods    like   Polymerase  
 
Chain   Reaction    which   detects   the   mecA  gene.   Detection   of   genes   
 
coding    for   resistance   by    molecular   techniques    is    superior    to   all   
 
other    methods    and    considered    to     be     the    gold standard [64]     for    
 
antimicrobial    susceptibility    testing ,   but    could   not   be   adopted    by    
 
all    laboratories   as  a  routine   procedure   since   it  requires   costly    and     
 
sophisticated   equipments. 
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                                Determination  of   M.I.C   value   of   any  antimicrobial    
 
agent   is   the   most  sensitive  method   of   susceptibility  testing. M.I C  is  
 
the  lowest   concentration   of    any  drug  which  causes  inhibition  of   the  
 
visible   growth of   microorganisms [63] . E test   is  one  of   the  methods  of   
 
determination   of   MIC  which   is   simple  and  could   be   easily  adopted    
 
by   any   laboratory.  E.Test   is  a  gradient   diffusion   test [63]  which   uses    
 
a  non porous   plastic strip  that  has been  impregnated  with   antimicrobial   
 
agent    calibrated    with    M.I.C  values   that  cover  15  twofold  dilutions.   
 
The    strip    is    placed   on   the   surface   of    the   agar   inoculated   with   
 
S.aureus.  After  incubation  for  24 hours   at   35 degree C,  M.I.C   is   read    
 
at   the   point   where  zones  of   inhibition  intersect   at  the  strip. 
                                               
                        O.R.S.A.B  is  also  one  of   the    sensitive   methods   which  
 
can    detect   MRSA   in   clinical   isolates [3] . ORSAB   is   a  modification   
 
of   Mannitol   Salt   Agar    supplemented    with  Oxacillin [46]  and  an  acid  
 
dependent   chromogenic   component,    aniline   blue.   If    the    inoculated  
 
specimen    contains    MRSA,   it   will   show   growth   after  incubation  at  
 
35 degree C  for 24hrs.  The   growth    will    be    identified   by   the   color   
 
change     of     the   medium    from    grey  to  deep  blue.  If   the  inoculum   
 
contains    Methicillin    sensitive     S.aureus    it     fails    to    grow    in  the 
 
O.R.S.A..B   medium   and  the  color  will  not  change. 
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                               Disc diffusion  method  uses  Methicillin  or  Oxacillin or  
 
Cefoxitin    discs [30]    to   find   out    the    susceptibility    of     S.aureus   to 
 
Methcillin   by   Kirby Bauer   method.    Since   Methicillin   is   an unstable  
 
compound   either   Oxacillin   or   Cefoxitin    discs  may  be used  to screen  
 
MRSA.  Cefoxitin  is  the  potent    inducer   of   mecA gene [117]   and   hence   
 
Cefoxitin   is  the  most   reliable  to  detect   MRSA  by   this  method.  Disc   
 
containing  30 microgram  of   Cefoxitin or   5 microgram   of   Oxacillin   is   
 
placed   in   Muellar  Hinton  agar  medium   inoculated   with  S.aureus  and   
 
the   zone  of   inhibition  is   observed    after   24hour   incubation   at 35◦ C.  
 
Many  studies    have  been  conducted   by  comparing  these  methods  with  
 
variable sensitivities  for each  method. 
                                            
                                                
                                               The  aim  of  this  study  was  to  compare  the   
 
efficacy  of  3 different   methods namely  E Test, ORSAB method, and  disc  
 
diffusion    method   with   Oxacillin  and  Cefoxitin  discs   for  detection  of  
 
MRSA   in   various  clinical   isolates   and  to  choose   the  most   sensitive 
 
and  economical  method  for  routine  sensitivity  testing in  Microbiological    
 
 laboratories. 
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AIMS   AND  OBJECTIVES 
 
1.To   find  out   the   prevalence   of  Methicillin   Resistant  Staphylococcus     
aureus   (MRSA)    infection   in   varied   clinical   samples  collected   from 
Govt. Rajaji  Hospital  (GRH),  Madurai. 
  
   
2.To  understand   the   distribution  of    MRSA    in   different   age   groups   
and  the  clinical   conditions  associated  with  MRSA  infection.                           
 
3.To  compare  the   various  phenotypic   methods  in  the   identification  of 
MRSA    with    PCR    and    to    find    out     the    most   sensitive,   easily  
available   and   economic  method   which   is  close   to   PCR   that  can  be  
recommended   for    routine    screening    of    MRSA    in  Microbiological  
laboratories. 
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REVIEW OF  
LITERATURE 
  -  
REVIEW OF LITERATURE 
   
 Harrison’s[49]  text  book  of   Principles of  Internal  Medicine  
 
(17th edi. P: 749)  states  that  infectious  diseases  remain  a  major cause  of      
 
debility    and    death   and    responsible    for    worsening    of   the   living     
 
conditions   of   millions  of    people    around   the   world.  Staphylococcus   
 
aureus  was  discovered   by   Sir.Alexander Ogston[22]  in  1880  in  Scotland 
 
(Curran.JP,   Al.Salahi 1980).    S.aureus     is    responsible     for    serious   
 
infections among  the  elderly  and  neonates. Franklin and Lowy (1998)[ 33]  
 
has  stated  that  even after more than  hundred years later S. aureus  remains   
 
a   versatile  and   dangerous   pathogen   in  humans. Melish   and  Glasgow   
 
(1971)[85]  reported  more than  200 cases   of    neonatal   sepsis   caused    by    
S. aureus in a period of one year. Most   of   the   cases   of   neonatal   sepsis   
were    hospital    acquired    and     mortality    remains    high   among    low  
birth    weight   infants   as   documented   by     Esperson [28]  et  al   (1989).    
Jensen  et  al    (1993)[54]         reported      104     cases     of      Staphyococcal    
Meningitis     during    the     period      1986-1989.     Vance.G.Fowler  et al  
(2005)[124]      identified   31.4%     etiology    of     S.aureus    among  the total   
no. of   1779   cases  of   Infective   Endocarditis.    Wang   et al    (2007)[124]     
have    documented   124    cases   of    Staphylococcal    origin   among  558   
patients     of     Prosthetic   valve    Endocarditis.   Fowler   et al   (2008) [31]    
12 
  -  
 have   documented    that    43 %    of    Bacteremia    among    724   cases   
were    due   to   Staphylococcus aureus.   
                          
                         Discovery  of   Penicillin  by   Alexander  Fleming    in  1928   
 
(Wain Wright.M 1986)[130],  Sulphonamides  by Gerhard Domagk  in   1936   
 
(Tilles.S.A 2011) [120] and discovery of  Streptomycin by Walksman  in 1943   
 
(Comroe.J.H 1978)[19 ]        paved     the      way   for    antibiotic    revolution.      
 
According    to  Sutherland .  et al  (1964) [114] the   resistance  of  S.aureus   
 
to   Methicillin   was  not    due   to   increased    ability   to    inactivate    the    
 
drug     but    to     intrinsic   insensitivity     to    Methicillin.    Malouin  and  
 
Bryan  (1986)[72]    described   the  alteration  of   Penicillin  Binding  Protein    
 
(PBP2a)  as  the  mechanism of  drug  resistance  in   betalactam  antibiotics.      
 
Lupski(1987)[71]  described  rearrangement  of  bacterial   genome  generated   
 
by   transposons,    integrons    and   insertion  sequences   as   an    important   
 
molecular   mechanism    of    drug    resistance.   Waxman (1988) [131]   also    
 
pointed   out   the    same  mechanism   in Methicillin  resistance.  According   
 
to  Mark.C.Enright  (2002)[27]   the  altered  PBP2a     is   coded   by  mec A  
 
gene ,  carried   on   Staphylococcal  Cassette  Chromosome  (SCC mec).                         
                                    
                                 Mark.C.Enright    (2002)[27]    has     documented   that   
 
Methicillin,    introduced    by   Beecham   in   1959    was    used    to    treat   
 
infections caused  by  penicillin  resistant  S.aureus. Because   of   its toxicity     
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such   as   aplastic  anaemia   (Harrison 17th edi.p.664) [50]    and    interstitial     
 
nephritis  (Mandell’s  principles of infectious diseases. 17th  edi.p.317.) [73]    
 
Methicillin   is   no  longer  used  nowadays .  According   to   Van  Beikum  
 
(2001)[125]   Methicillin  Resistant  Staphylococcus  aureus (MRSA)  emerged     
 
in    Britain    hospitals    in   1960  and   is   steadily  increasing   worldwide.  
 
Verhoef et al (1999)[129]   documented  the   incidence   of  MRSA  in   many   
 
countries   as   40% - 70%   except    in  Netherlands   where   the   incidence  
 
was less than  0.5% .    
 
                                  Nicole (2006)[93]   has  defined   Health care  Associated   
 
MRSA  infection  (HA-MRSA) as  infection  occuring  in  people  who  have   
 
recently   been   to   hospitals  or   other   health  care  facilities.  Community   
 
Acquired    MRSA   (CA-MRSA)  infection  occurs    in   otherwise   healthy   
 
people   who   have   not     been      to     hospital    recently.   According    to     
 
Ulrich Seybold  (2006)[121]  Nosocomial  MRSA   infections  are  defined  by         
 
MRSA    positive   blood   culture   obtained    more    than   48   hours   after    
 
admission;  Community   Acquired   MRSA    infections   are     defined    as    
 
MRSA    positive    blood   cultures   within   48   hours   of  admission. Stan  
 
Deresinski   (2005)[115]   documented   that  MRSA  has    undergone     rapid  
 
evolutionary    changes   and   has   spread    beyond   Health   Care  facilities   
 
and   emerged   as   a   Community Associated   pathogen  and a  new  public   
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health  threat.  Klevans et al  (2007)[61]  had  documented  40%   to   60%  of    
 
MRSA   in  USA  and  United  Kingdom  and   18000   deaths   in   USA   in    
 
2005 were   due   to  HA -MRSA   infections. Mishaan   (2005)[87]    reported    
 
that    76%    of    infections    due   to   Community   Acquired   S.aureus   at   
 
Texas   childrens’ hospital  were   caused  by   MRSA.  In   a    study   during      
 
the   period    between   Jan.  1993   and   Nov. 1994  Pulimood and Lalitha  
 
(1996)[102] recorded  a prevalance of 24% of  MRSA  in a tertiary care centre    
 
in Vellore, India.  In  their  study  all  the  MRSA   isolates   were   multidrug    
 
resistant     and    uniformly    sensitive     to    Vancomycin. Anupurba et al  
 
(2003)[7]  have  shown   in  a  study  an   incidence  of   54.85%    of    MRSA    
 
in    Uttar Pradesh,  Northern  part of  India   whereas   Rajaduraipandi etal 
 
(2006)[103]    had    documented    the   prevalence    of   MRSA   as 37.9%  in   
 
Southern  Districts   of  Tamil Nadu,  India.                                    
                         
                        Naimi(2003)[92] had documented  that  among  the 1100 cases     
 
of   MRSA   infections   in    Minnesota    85%     was    Hospital    Acquired   
 
and    15%    was    Community  Acquired   and   most  of    the   CA- MRSA   
 
strains  carried  Panton Valentine Leucocidin (PVL) genes  and  caused  skin   
 
and  soft  tissues infections.In a study  by Cosgrove(2003) et al[20] 52.3%  of   
 
nosocomial   infections  in   Intensive  Care  Unit  patients  were   bacteremia   
 
due   to   MRSA   and   the   mortality    rates    were    higher.  According  to  
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Cassandra  (2003)[16]     the    prevalence  of   MRSA    among    hospitalized    
 
patients  was  30% - 37%  and  most of  them had  risk factors  such as  weak  
 
immune  system,use  of  quinolone  antibiotics  and  intra venous drug abuse.   
 
Lowfy (1998) [69] in   his  study   proved   the    high    incidence   of   MRSA   
 
infection   in I.V drug  users.                                                                                                        
 
                     Pan et al (2002)[96] has  analysed  prevalence  of MRSA among  
 
295  prisoners    in    San  Fransisco     during   the    period    1997  to   2002     
 
and  concluded that the prevalence  of  MRSA  increased  from 29% to 74%.  
 
Mary Healy(2004)[83]  reported   8  cases  of  infants  with   bacteremia  in  a   
 
neonatal  intensive  care   unit  due  to  MRSA and  the  isolates  had  genetic  
 
characteristics   of   MRSA   of   community  origin. Henry.C.Baggett  et al   
 
(2004 )[52]   compared 34  patients  with  MRSA  skin  infection  with  control  
 
subjects   to  determine  the  risk  factors   and   concluded   that  all   patients   
 
received     more    antibiotic   courses     during  the 12   months   before  the  
 
outbreak  than  the control  subjects. Ziderman  et al (2004)[136] documented  
 
235  CA-MRSA    infections   among   military  recruits   and   close  contact   
 
between   recruits   had  contributed  to  the  spread  of  MRSA.  Nolen.E.lee  
 
(2005)[94] documented  30 cases  of  MRSA  infection  that occurred  in  HIV   
 
positive  men   who  had  sex  with  men  in LosAngels. Bayer(2005) et al[10]  
 
documented  necrotizing fasciitis caused by CA-MRSA in patients with  risk  
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factors like  I.V drug  use , Diabetes  mellitus, Chronic hepatitis  and  cancer.   
 
Rossi etal (2005)[106]  isolated  151 cases  of  CA-MRSA, SCC mec   type IV   
 
strain  from  nosocomial blood stream  infections.  Ulrich Seybold(2006)[121]   
 
has  described   the   risk  factors  for  HA-MRSA  infections   such  as  prior  
 
admission   to  an   acute  care   facility,  use  of   central  venous  or   urinary  
 
catheters  and  prior surgical  procedures. 
 
                                   Mark.D.king et al (2006)[60]    identified   279   MRSA   
 
isolates    as   USA  300  clone    among   skin   and   soft    tissue   infection.  
 
Costi.D.Sifri (2007)[21]   reported  a   fatal   case  of   Brain   abscess  due   to  
 
CA-MRSA  strain   USA  300.  In a  stydy  by  Mukesh Patel(2007)[91] 57%  
 
of MRSA isolate   were  CA-MRSA  of  USA300  genotype   in  nosocomial   
 
settings .   Tacconelli et al (2008)[118]     have    proved   the   association   of   
 
prolonged  antibiotic   exposure  to  quinolones   with  CA-MRSA  infection.    
 
Reinout Naesens (2009)[104]   reported   a  case   of    CA-MRSA  bacteremia  
 
with   cavernous   sinus  thrombosis,   meningitis   and   brain   abscess   in  a   
 
previously  healthy  patient.  According   to  Savitha Nadig  et al  (2010)[108]  
 
Epidemic MRSA 15 (EMRSA),  a variant  of HA-MRSA first   appeared   in   
 
United Kingdom during early nineties and became  predominant HA-MRSA   
 
strains  and  they  have  reported  EMRSA 15  strain  causing   brain  abscess   
 
first time  in  India. 
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                                  Most  of  the  CA-MRSA  infections  are  found  to   be  
 
associated    with  PVL   and   are   SCC  mec type IV.  Gillet etal[37]  (2002)   
 
reported  16  cases   of  necrotizing   pneumonitis   with   a   crude   mortality    
 
rate   of   75%.   Lisa Saiman[67]    (2006)    reported   8  cases   of   skin  and   
 
soft   tissue   infections  caused   by  MRSA    in  post partum    women   and   
 
all    isolates    contained   SCC   mec  type   IV    and    PVL   genes.  Beiger  
 
(2004) [11]   identified   10 cases  of  cellulitis   and  skin   abscess   caused  by   
 
CA-MRSA  USA 300  strain  which  carried  PVL  genes   in a  college  foot  
 
ball   team.  This    was   supported    by    Fraser  and  Boo  (2005)[35]   who   
 
isolated  8   cases  of   MRSA  skin  infections   caused   by  USA 300  strain   
 
carrying    SCC IV   and    PVL   genes.  According    to    Jerome  (2005)[29]   
 
Panton   Valentine   Leucocidin    was   mainly    associated    with    primary    
 
cutaneous   infections   like    abscess   and   furuncles  but  recently  causing   
 
pulmonary   infections   also.  Francis   (2005)[32]    documented   4   cases  of   
 
necrotizing   pneumonia of MRSA USA 300  with  PVL  origin.  
                        
                     Gonzalez(2005)[38]  reported  41 cases of  osteomyelitis of PVL  
 
positive   S.aureus   etiology. Loren.G.Miller  (2005)[86]  also  isolated  PVL  
 
and      SCC   mec IV    positive   S.aureus    from   14  cases   of  necrotizing   
 
pneumonitis. Moroney et al (2007)[90]  proved  that  SCC IV  and   PVL  are   
 
associated   only   with   CA-MRSA   and    HA-MRSA   carried   only  SCC   
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type  II  complex without  PVL  genes.  Al Rawahi  (2008)[2]    demonstrated   
 
an  increase  of   nasal  carriage  of CA-MRSA   strains  with  positive   PVL    
 
gene    in   IV  drug   users   over  a  period   of   six    years.  Pierre tattavin  
 
(2008)[99]   in  a  long term   follow   up  study   has  documented  that  82.1%    
 
of  MRSA  isolates in San Fransisco  jail  population  were USA300  strains. 
                    
                          Stan Deresinski et al (2005)[115] has listed out various drugs   
 
such  as  Vancomycin, Daptomycin,Linezolid, Clindamycin  and Rifampicin   
 
for  the  treatment  of  MRSA  infections   and   documented   that  Linezolid     
 
was  superior to   Vancomycin  in  HA-MRSA  pneumonia. Richter et al[105]    
 
(2003)  confirmed   the   efficacy  of   Daptomycin   in  193  MRSA   isolates   
 
by  broth  microdilution  and  disc  diffusion  methods.  This  was  supported      
 
by   Carpenter(2004)[15]     who    documented   that   Daptomycin   a  cyclic   
 
lipopeptide ,  provides  effective   antibacterial   activity   against  Methcillin   
 
Resistant   and   Sensitive   S.aureus,     Vancomycin     Resistant    S.aureus,  
 
Vancomycin Resistant Enterococci   and   Penicillin Resistant Pneumococci.   
 
Steenberger[55](2005)  also    confirmed  the  efficacy  of   Daptomycin  in  a    
 
study.   Peter  Garber   et al  (2005) [98]   documented   about  the    superior     
 
bactericidal    effect   of    Daptomycin   than  Vancomycin   in  experimental    
 
meningitis   caused    by   MRSA    Hanaki   et al  (1997)[47]    demonstrated    
 
Vancomycin   Resistance     even   after   29  days   of   treatment   in  sternal   
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surgical   site  infection  in an  infant  who  had  undergone  cardiac   surgery   
 
for  pulmonary  atresia. Sierdazki   et  al (1999)[109] documented  a  case  of   
 
79 year  old  man  with  end  stage  renal  disease  with  intravenous  catheter  
 
failed   with  vancomycin  therapy.  Mangili (2005)[82] reported  one  case  of  
 
MRSA    bacteremia    which    was    resistant   to   both   Vancomycin   and    
 
Daptomycin .This  was  supported by another   study   by  Daniel.J.Skiest[23]  
 
(2006).  Fransisco  (2006)[34]   documented   Daptomycin   resistant   MRSA   
 
isolates    during    treatment  of   bacteremia   and    vertebral   osteomyelitis    
 
which     was    confirmed    by    M.I.C   and   Time    Kill   Curve   Analysis 
 
Kerry.J.Welsch (2010)[59]  reported Vancomycin  failure in  50% of  MRSA   
 
bacteremia  in premature  infants  and addition of Rifampicin was beneficial. 
                        
                       Accurate    and  early  detection of    MRSA is  mandatory  for  
 
effective management of MRSA infections. Brown and  Edwards[14] (2005)  
 
in their  guidelines  for the detection of  MRSA ,suggested  various  methods   
 
such  as  Dilution   methods ,  E-Test , Agar screening  ,Disc diffusion, Latex  
 
agglutination   and  Molecular  methods. According  to Krishnan and Miles  
 
(2002) [64] mec A gene  detection  by P.C.R  is  the gold standard  to  confirm  
 
ambiguous   results   but   is   difficult   to   perform   in   routine   diagnostic  
 
laboratories ;   a  commercial  Latex  agglutination  test  Mastalex   has  been  
 
suggested  as  an  alternative  to P.C.R.Perez Roth et al (2001)[97] developed  
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a multiplex  P.C.R  which  can  detect simultaneously  mec A gene encoding   
 
high   level    Methicillin  Resistance   and  fem  B  gene  encoding  a   factor  
 
which is essential for  M.R genes  and  this is a  rapid ,sensitive, specific and  
 
accurate method. 
                      
                           Katrina   levi  et al (2003)[58]  observed  that  EVIGENE,  a  
 
commercial  gene  probe   kit  that  allowed  specific identification of MRSA  
 
in blood  cultures within  one  hour.  David and Robert(2004)[24]   described  
 
rapid    method   of   MRSA   detection   based   on    Real  Time   PCR   and   
 
Amplicon  hybridization  with a   fluorogenic  target specific  probe.Kristin, 
 
Daniel et al (2007)[65]  demonstrated    that   multiplex   P.C.R   can  be  used     
 
for   rapidly identifying   USA 300  isolates  and  this  was 100%  concordant    
 
with DNA sequencing. 
                            
                       Cavassini and wenger et al (1999)[17] documented  that  slide  
 
Latex agglutination  was  accurate  and reliable test which  identifies  MRSA  
 
from  colonies  on  agar  plates  within  15  minutes  and  the  sensitivity was  
 
100% , compared  to disc diffusion  and  Oxacillin  salt  agar screening  with  
 
sensitivities  61.30%  and  82.5% respectively. This study was  supported  by  
 
Griethuysen  et al  (1999)[45]  who  have reported  that  this  test  was highly  
 
sensitive  in   267 mec  A gene  positive  isolates. Van Leeuwen  (1999)[127]   
 
has concluded  that  due  to  excellent specificity and  sensitivity  the  MRSA  
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screen  Latex  test  which  detected  PBP 2a   in  90 out  of  90 cases  has  the  
 
potential   to be  used  for  routine   application  in  Microbiology laboratory. 
 
Sakoulas[107] (2001)   demonstrated    that  Latex  agglutination  method   for    
 
detection  of  PBP2a  antigen  was   comparable   to mec P.C.R  with  respect   
 
to     sensitivity    and    specificity    for   the   detection   of   MRSA. Veerle  
 
Compennolle[128]  et al   (2006)   in   a    study    concluded    that  use   of  a   
 
Chromogenic agar, MRSA-ID  combined with  Gram staining  and  Pastorex  
 
Latex agglutination  was  faster and  more specific  than  any  other  strategy. 
                              
                           Anniefelter etal(2002)[5]  compared  the  efficacy  of   three  
 
tests   and  concluded  that  the  Disc  Diffusion  method  using  Cephamycin  
 
antibiotics  Cefoxitin  and  Moxolatam  detected  100%  of  all   MRSA  was  
 
the  best  performing  test for  routine  MRSA screening   and  other methods   
 
like  Vitek-2   system   and  MRSA  screen   Latex  detected  only   94%  and    
 
97.6%  of  MRSA  isolates  respectively.Skov et al  (2003)[111]  demonstrated   
 
that    30  microgram    Cefoxitin   disc     in    Iso-  Sensitest   agar    method   
 
showed    100% sensitivity  and 99%  specificity  among 190 mec A positive  
 
isolates.   David  Velasco  (2005)[25]     tested   51    isolates    with   Oxacillin       
 
(5microgram)   Cefazolin,  Cefotaxime   and   Imipenem   (all 30microgram)  
 
discs,  E-Test  for  Oxacillin,  Microdilution  with  Oxacillin ,Agar screening   
 
test   with   6mg /L of  Oxacillin   and  Latex  agglutination   and   concluded   
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that  Cefoxitin  disc  which   showed   positive   predictive   value  90%   and    
 
negative   predictive   value   100%   was   the   best    method   for  detecting   
 
MRSA.  Fernandes et al  (2005)[30]   concluded    in  a  trial  with   Cefoxitin    
 
disc   for   isolation  of   MRSA   among  871  clinical   isolates  of   S.aureus   
 
that  Cefoxitin , as  the  surrogate marker  for  the  detection  of  MRSA  was   
 
accurate    method.  Swenson et al  (2005) [117]   documented   that   Cefoxitin   
 
disc  diffusion  test  can  be   used   to predict  the  presence  of  mec A  gene   
 
in   S.aureus   with   a  high   degree   of    sensitivity    and    specificity   and    
 
5 microgram  Oxacillin  disc  may  be replaced with 30 microgram Cefoxitin  
 
disc   for  routine  testing.  Skov  and  Smith[112]  (2006)   demonstrated   that  
 
detection  of   MRSA   by   Cefoxitin   based  method  was  not  affected   by   
 
temperature  variations between  35 and  36   degrees  whereas for  Oxacillin   
 
testing  temp. should  not  exceed  35 degree. 
                           
                        Hansen et al   (1985)[48]   developed  a    broth  by   using   cat   
 
ion  supplemented  M.H  broth   with  2%  Nacl , 10 microgram   Methicillin   
 
6 microgram Oxacillin  per ml and a tetrazolium indicator and  demonstrated  
 
that  96.9%  of 129 MRSA strains were  identified without any false positive  
 
results . Thompson et al (1992)[119] used  an  Oxacillin  containing Mannitol  
 
salt based   selective  medium on 936  respiratory  specimens  and concluded   
 
that  recovery  of  MRSA   isolate   was  45%   more   than  on  non selective  
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medium. Davies and Zadik (1997)[26]  compared  three  media  for detection   
 
for  MRSA namely   Baird    Parker   medium     containing      Ciprofloxacin     
 
(B.P.C).  Mannitol  Salt  Agar  (M.S.A)   and  M.S.A   with  Methicillin  and  
 
identified that   B.P.C  was  the  most  sensitive  method. Gunter Kampf et  
 
al [46](1998) evaluated    M.S.A  with  2microgram  of  Oxacillin  per  ml  for  
 
detection  of  Oxacillin  resistance  in 136 S.aureus  isolates  which  revealed  
 
sensitivity of   98.1%  and   sensitivity  of  95.1%.  Heck  and  Williamse[51] 
 
(1999)  for    the   detection   of   MRSA,   compared   MRSA   screen  Latex   
 
agglutination  test with O.R.S.A.B   and   concluded   that  the  sensitivity  of  
 
O.R.S.A.B   was   93%  and  that  of  Latex  agglutination  was  98.5%. 
                        
                          Louie(2000)[68]   evaluated   three   rapid   methods   for   the  
 
detection   of    MRSA - Probe   based   Velogene   Rapid   MRSA,    MRSA   
 
screen  Latex  agglutination   and   BBL-MRSA-ID   system  and  concluded   
 
that  Velogene  and  MRSA screen  rapidly identified  MRSA and  were able  
 
to    differentiate    Borderline    MRSA   (BORSA)   from    MRSA.  Prasad    
 
(2000)[101]    compared   Oxacillin   disc    diffusion,   6microgram    Oxacillin   
 
Screening    Agar    and   3 microgram   Oxacillin   Broth   methods   in   106  
 
clinical   isolates  and concluded  that  disc  diffusion  was  the  least  reliable    
 
and  3 microgram broth method  had the  highest  sensitivity and  specificity.  
 
Andrea  Becker et al[3]  (2002) documented   the  results  obtained  by  using    
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O.R.S.A.B  to  detect   MRSA  with  99% sensitivity  which  coincided  with  
 
the    same   study   by    Simer  et al  (2001)[110].    Wertheim.H   (2001)[134]    
 
documented    that   Phenyl   Mannitol  Broth    containing   Aztreonam   and    
 
Ceftriaxone   improved   the  rate  of  detection  of  MRSA  by  >45%   when     
 
compared  to conventionl disc method  and  this method  was    implemented    
 
in  the  routine  MRSA  screening in Dutch  hospitals. Kluytisman (2002)[62]  
 
compared    two  selective    media ,  CHROM  agar    and     O.R.S.A.B   for    
 
identification   of  MRSA  and concluded that the  sensitivity and  specificity  
 
for CHROM agar  was  98.6% and  97.1%  and  for  O.R.S.A.B   was  97.1%   
 
and  92.1%.   Blanc  et al[12] (2003)   evaluated   O.R.S.A.B    for    screening   
 
MRSA  and   documented  the sensitivity to  be  94%  at  24 hrs. Hong Fang  
 
et al  (2006)[53]    in  a   study    concluded   that   Cefoxitin  based  broth  was   
 
proved   to    be    more   sensitive   and  rapid   than  Oxacillin  based   broth   
 
especially   for   the  detection   of   hetero resistant  strain   of   MRSA.  In a  
 
comparative   study      Mohammad Rahbar  (2006)[88]      documented    that   
 
O.R.S.A.B   showed   96%    sensitivity   and could be a reliable  method  for  
 
detection   of  MRSA. Lisa Louie et al (2006)[66]   compared 2  Chromogenic  
 
methods ,  MRSA-select   and   M.S.A  with  8 microgram  of  Cefoxitin  for  
 
detection  of MRSA from 6199 clinical samples and found the MRSA-select  
 
medium  to be more sensitive  and  specific. This was supported by the study  
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of   Wolk (2009)[135]   who     concluded    that    MRSA-select agar   can   be  
 
comparable  to   X-Pert  MRSA P.C.R.   Stokes et al (2006)[116] compared  4  
 
methods  namely  MRSA-select agar , CHROM agar, M.S.A  with  Oxacillin   
 
and   M.S.A  with  Cefoxitin  for  isolation  of  MRSA  and  documented that  
 
M.S.A   supplemented   with  Cefoxitin   showed  the  highest  sensitivity  of   
 
99.1%.  Ahamed Y.Coban (2006)[1]   described   two  calorimetric  methods,  
 
Resazurine Microplate  method  and  Nitrate reductase  assay   for   detection  
 
of   MRSA  and   confirmed   that  the    results    of     both   methods    were    
 
in     concordance    with   standard   methodologies.   Bram et al   (2006)[13]    
 
used  a   new  Chromogenic  medium MRSA-ID    for   detection  of  MRSA   
 
in   998   S.aureus   isolates   and  the sensitivity    was  96.4%  in 24 hrs  and  
 
improved   to 98.8%  after  48 hrs.Van Hal et al  (2007)[126]  performed   two    
 
molecular   methods    (IDI- MRSA P.C.R  Assay    and    Genotype   MRSA   
 
Direct  P.C.R)  and  three  selective MRSA  agars (MRSA-ID,MRSA-select ,  
 
CHROM  agar  MRSA)     on   205    swabs    for    MRSA    screening    and   
 
concluded   that   IDI-MRSA   was   the  most  sensitive  method  among   all   
 
the  methods. Junkins et al[57]  (2009) demonstrated  the improved  detection    
 
of  mec A mediated  resistance  in S.aureus by two automated   susceptibility  
 
testing   systems,  BD-Phoenix   and   Vitek -2 with  addition   of   Cefoxitin.   
 
Anila Mathew et al   (2010)[4]    in  a   study   with    610   S.aureus   isolates    
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tested  for   Methicillin  resistance   by  O.R.S.A.B, 30 microgram  Cefoxitin  
 
disc  diffusion and  Oxacillin M.I.C  concluded  that  the results of  Cefoxitin   
 
disc  diffusion  were  in  concordance  with  P.C.R  for  mec A gene.  Surbhi  
 
Malhotra et al (2010)[113] evaluated  and compared the potential for   MRSA    
 
detection of  five  chromogenic  media;  Brilliance- MRSA agar,  Chrom-ID,    
 
MRSA-Select,    CHROM agar    and   BBL-CHROM  agar   and  concluded    
 
that CHROM agar   and  BBL-CHROM agar  gave  the  best  overall   results    
 
for   detection   of   MRSA. 
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                      This   study   was  conducted  in  Government  Rajaji  Hospital   
 
Madurai ,   attached   to   Madurai   Medical   College , Madurai. The   study  
 
period    was     from   December   2010  to   June    2011. Ethical  committee   
 
clearance     from    the    Institution   was   obtained     before    starting    the    
 
study    and    informed    consent     was    received    from    the  patients  or    
 
parents   in case   of   pediatric    patients  before   collecting  the  specimens.   
 
A   total   of   240   clinical    samples    that   include   Blood,  Pus,  Sputum,   
 
Throat  swab  and    Urine   were  collected   from  the   patients   who   were    
 
admitted    at    Govt.  Rajaji  Hospital, Madurai. 
 
 
Inclusion criteria: 
                                    
Male  and  female  patients of   all age  groups  were  included  in  this study.  
 
Patients    with    provisional     diagnosis     of      Septicemia,    Pyrexia    of    
 
unknown    origin,      Urinary    tract   infection,     Wound     infection    and   
 
Respiratory infection    were  included. 
  
 
Exclusion criteria:  
 
Patients  suffering  from  infections  of  G.I.T,  Bones&Joints, Genitals,  Ear,  
 
Eye  and  CNS    were  excluded. 
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Collection of specimen: 
      
 
Collection of Blood sample 
 
                        Blood   samples  were  collected by strict aseptic technique. 
 
The   skin   over  the  veni puncture  site  approximately  5cm  diameter  was  
 
cleansed  thoroughly  with  70% ethanol  followed  by  povidone  iodine  and   
 
the   skin  was  allowed  to  dry   at least  for  one  minute   before  collecting   
 
the   sample.  5 ml   of  blood   was   collected   in   50 ml   of    Brain   Heart   
 
Infusion   broth  (B.H.I) in adults.  In  the  pediatric  age    group  1 to 2ml of  
 
blood  was  collected  in  appropriate  quantity  of  B.H.I.  
 
Collection of  Pus sample 
                         
                         Sterile   cotton-wool    swabs    were  used   to  collect   the  
 
sample   from   the   infected  sites. Two  swabs  were  collected  from  every  
 
patient,  one  for  direct  smear  and  the  other  for  culture. The  swabs  were   
 
transported   in    sterile  test  tubes  to  the  laboratory. 
 
 
Collection of Sputum sample 
                        
                            The  patients  were asked to cough deeply before collecting  
 
the    sputum   to  avoid  mixing  of  much   saliva  with  the  sputum.  It  was   
  
collected     in    the    morning    before     any    mouth    wash    was    used.    
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Clean,  dry,  sterile,  wide  mouthed  and  leak  proof   containers  were  used   
 
for  sputum  collection. 
 
Collection of Urine sample 
                        
                       Patients   were   instructed  for the proper  collection of   urine 
samples  without  any  contamination.  Male Patients  were  asked  to  retract 
the  prepuce  and   clean  the  external  urethral  meatus   with   clean    water  
and     to    collect    the    mid   stream    urine.      Female     patients     were   
asked    to   clean    the   area   around    the   urethral   opening    with   clean  
water    and   to  dry   the   area  with  sterile  gauze   pad.    The    urine   was 
collected   with  the  labia  held  apart. 
 
Collection of throat swab 
 
                   By  using  a  tongue  depressor   the   posterior   pharyngeal  wall  
 
was     viewed    and    specimens   were   collected    with   a   sterile   cotton    
 
wool    swab    and  transported    in  a  sterile   test   tube  to  the  laboratory. 
      
Processing of samples:  
 
                 The   collected  samples  were  properly  labeled with Name ,Age,  
 
Sex   and   I.P/ O.P No.  of   the   patient , Date   and  time  of   collection  of   
 
the  sample  and   brought  to  the   laboratory  and   processed   immediately.  
 
Blood samples:   BHI   broth  containing   Blood   samples   were  incubated    
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at  37◦C  for  18-24 hrs  after  which the  broth  which  showed turbidity were   
 
sub  cultured   on to   the   following   media  using   sterile  technique.  
 
a) Nutrient Agar 
 
b) MacConkey Agar  
 
c) Blood Agar  
 
d) Mannitol Salt Agar 
 
 
The   broths   which   were   clear  were   kept   for   further   incubation   and  
 
reported   as  Negative  after  48  hrs  of  incubation. 
 
 
Urine  samples: The  Urine   samples   were   centrifuged  at  3000  rpm  for  
 
5mts.  The  sediment  was  used   for direct Gram stain  and   inoculation   on  
 
to  the  above  media  and  incubated  at 37◦C  for  18-24 hrs  aerobically. 
 
 
Sputum samples: Direct   Gram stain   was  done  on  Sputum samples after  
 
which   inoculated   on to   above  media  and   the   inoculated   plates   were   
 
incubated at 37◦C  for 18-24 hrs  aerobically. 
 
 
Pus samples:  Direct  Gram   stain   was   done   on   pus  samples   followed  
 
by  inoculation   on to  the  above  media   and  the   inoculated  plates   were  
 
incubated  at 37◦C  for  18-24 hrs  aerobically. 
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Throat swab:After  doing  direct  Gram  stain,  all  throat  swab   specimens  
 
were  inoculated  on to  the  above  media  and  incubated  at 37◦C  for 18-24  
 
hrs aerobically. 
 
 
 
Culture identification 
 
                           The   organisms   were   identified  by   colony morphology,  
 
Gram stain,   biochemical   reactions   and   other  special tests.   
 
 
 IDENTIFICATION OF STAPHYLOCOCCUS SPECIES : 
 
                 Staphylococcal    species   were   identified  by  Small  (1-3 mm in 
diameter)    circular,   low  convex,     opaque    colonies    in   Nutrient   agar    
and     Gram   positive    cocci    in   clusters   in   Gram  staining .Organisms  
which  produce  golden  yellow  pigments  in  Nutrient agar,  Beta hemolysis  
in   Blood agar ,  pink    coloured    tiny  colonies   in  MacConkey agar   and  
yellow  colonies  due   to   Mannitol   fermentation   in   Mannitol   salt   agar  
with   positive   Slide   and     Tube    Coagulase     tests,      were    identified    
as     Staphylococcus aureus.   Organisms    which  were  negative  for   these    
properties    were    identified    as   Coagulase   negative  Staphyococcus. 
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               Biochemical   tests   like  Catalase test,   Phosphatase test,   D.Nase 
agar test,  Methyl Red,    Voges Proskauer    and  Urease   tests   were    done  
for Staphylococcus aureus which showed positive reactions.  
IDENTIFICATION TESTS:       
GRAM STAINING: Smear   was  prepared  from  the  test  organism  taken  
  
from   the   agar  plate,  air dried  and  heat  fixed.  The  smear   was  flooded  
 
with 0.5%   methyl violet  and  washed  with  water  after  1 minute   Gram’s  
 
iodine  is  added  to the  smear  and washed  with  water  after 1 minute. This  
 
was   decolorized   with   one  or  two  drops  of  acetone   and    immediately  
 
washed    with   water.  The   counter  stain,  1:10  dilute  carbol fuchsin  was   
 
added  to  the  smear  and  washed  with  water after 1 minute, the smear was  
 
dried  with  the  blotting paper  and  viewed  under oil  immersion  objective. 
 
Violet  colored  cocci  arranged  in clusters  were  identified as  S.aureus.     
 
CATALASE TEST:   
 
Procedure: 
  
2-3  ml  of   3%  Hydrogen   peroxide  was  taken   in a  clean  test tube. Few     
 
colonies of  the  test  organism were  taken  from the agar plate with a  sterile  
 
wooden  stick or glass rod and  immersed in the Hydrogen peroxide solution. 
 
Interpretation: 
 
Brisk  effervescence   produced   within  10 secs  is   considered   as Catalase  
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positive. The  organisms  producing  Catalase   will  split Hydrogen peroxide  
 
into   water    and    Oxygen   and    the   effervescence   was   due  to  release   
 
of Oxygen. Catalase  positive  isolates  were  identified  as  S.aureus. 
 
COAGULASE TEST:   This  test  was  done  to  identify   S.aureus   which  
 
produces  the  enzyme  Coagulase   that  causes  plasma to clot by converting  
 
fibrinogen   to  fibrin. Two  types  of  coagulase  are  produced  by  S.aureus. 
 
a) Free    coagulase   which   converts  fibrinogen  to  fibrin  by  activating  a  
 
coagulase  reacting  factor present  in  plasma. Free coagulase  is detected by  
 
clotting  in  the test  tube. 
 
b) Bound  coagulase  (clumping factor) which  converts  fibrinogen  to fibrin  
 
without  requiring reacting factor. It can be detected by clumping of bacterial  
 
cells  in  the  rapid slide  test. 
 
Procedure : 
 
Slide test method: 
 
1.A drop of saline was placed on each end of a clean slide. 
 
2.A colony of  the  test  organism  was  emulsified  in  each  of  the  drops  to  
 
make  two  thick  suspensions. 
 
3. A  loopful  of  plasma  was  added  to  one of  the  suspensions and  mixed  
 
gently:  plasma was not added to 2nd suspension which was used as a control. 
 
Interpretation:  Clumping  of  organisms  within 10  secs was interpreted as  
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positive  slide  coagulase  test. 
 
Tube test method: 
 
Three  small  clean  test  tubes  were  taken. One  tube  was  used  for  testing  
 
the   isolate  from  primary  culture   plate. The  other   tubes   were   used  as  
 
positive  and  negative  controls. 0.8 ml of  24 hr  broth  culture  of   S.aureus  
 
was added to one tube and kept as positive control.To another tube  0.8 ml of   
 
24hr broth culture of CoNS was added  as negative control. 0.2 ml of plasma  
 
was  added   to  all  the  tubes  and   incubated  at  35◦C.  After  4  hours   the  
 
tubes  were   examined  for   clotting.  The   tubes   were  left  at  room temp.  
 
overnight  and  examined  again if  no clotting  occurred. 
 
DNase TEST: 
 
This test was done to  identify S.aureus  which  produces  deoxyribonuclease  
 
enzyme, which  is  capable of  hydrolyzing  DNA. 
 
Procedure: 
 
1.The  DNase  agar  plate  was  divided  into 8 sections  by  drawing lines on  
 
its  bottom  and  the   sections  were   numbered   to  denote  the   strain to be  
 
applied  to  them.  
 
2.A colony  was  picked  from  the  primary  culture   plate   spot   inoculated  
 
on  to  a  small  area  of  the  medium. 
 
3.Known  DNase positive and DNase  negative cultures were spot inoculated  
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on other  sections  as control. 
 
4.The  plate  was  incubated  at  37◦C  for  18-24 hrs. 
 
5.After  incubation  the  plate was  flooded  with  a  few  ml  of 1mol/L,3.6%  
 
hydrochloric acid  to  precipitate  unhydrolysed  DNA. 
 
6.The  plate  was  examined  after 5 mts. 
 
Interpretation: 
 
DNase  positive  S.aureus  produced  clear zones  around  the  colonies. 
 
METHYL RED TEST(MR TEST): 
 
MR   test   is  a   quantitative  test  for  acid   production   requiring   positive  
 
organisms  to produce  strong  acids  (lactic acid,acetic acid and formic acid)  
 
from  glucose   through  the  mixed  acid  fermentation  pathway. 
 
Procedure: 
 
1) The   test   organism    was   inoculated   in   5ml  of   glucose    phosphate    
 
peptone   water   and  incubated   at  37◦C  for  48 hrs. 
 
2)After  incubation  5 drops  of  MR  reagent  was  added  to  the  broth. 
 
Interpretation: 
 
The  organism which  produced  strong  acids  from glucose  developed a red  
 
colour    immediately   in  the   surface  of  the  medium   indicating   the  PH  
 
less  than  4.4   and  was  taken  as  positive  MR  test. All  S.aureus   isolates  
 
were   MR   positive.  
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VOGES PROSKAUER TEST: (VP TEST) 
 
Procedure: 
 
1)The  organism  isolated  from   primary  culture  plate   was   inoculated  in  
 
glucose  phosphate  peptone  water and  incubated  for 48 hrs at 37◦C. 
 
2)1ml  of  broth  was taken  in  a separate  test tube  and   0.6ml of 5%  alpha  
 
naphthal  and  0.2 ml  of  40%  KOH  were  added  and  shaken  well. 
 
Interpretation: 
 
A positive  test  was represented  by  the  development of  a red color  within  
 
15  to  30  mts  after  addition  of   the  reagent   indicating   the  presence  of  
 
diacetyl,  the  oxidation  product  of  acetoin. All S.aureus  isolates  were  VP  
 
test  positive. 
 
UREASE TEST: 
 
Procedure: 
 
The  organism  isolated  from  NAP was  heavily inoculated in Christensen’s  
 
urease agar  and  incubated  at  37◦C  overnight. 
 
Interpretation: 
 
The  organism  which  possessed  the  enzyme  urease, hydrolysed  urea  into  
 
ammonia  and  CO2  and  increased  the  pH  of the medium producing  pink  
 
color. All S.aureus  isolates  were  Urease  test  positive. 
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OXIDATION – FERMENTATION TEST: (O.F TEST) 
 
Procedure: 
 
Two  tubes  of  O.F  medium  were  inoculated  with  the  organism   isolated  
 
from  NAP  by   stabbing  3 to 4 times  halfway  to  the  bottom of  the  tube.  
 
One  tube  was  promptly   covered  with  a layer of  sterile   melted  paraffin  
 
jelly   to a depth  of  5 to 10 mm, leaving the other  tube open to the air; both  
 
tubes  were  incubated  at 35◦C  for 72hrs  and  examined  daily.  
 
Interpretation was done as below. 
 
        Open tube       Sealed tube    Type of metabolism 
      Acid(yellow) 
 
   Alkaline(green)          Oxidation 
      Acid(yellow)      Acid(yellow)        Fermentation 
    Alkaline(green)    Alkaline(green)       Asaccharolytic 
 
Observation: 
 
S.aureus  utilized  glucose  by  fermentation. 
 
PHOSPHATASE TEST: 
 
Procedure: 
 
S.aureus  culture  was   inoculated  on to  Phenolphthalein  diphosphate  agar  
 
medium   and  incubated  at  37◦C  overnight. After  incubation  a few  drops   
 
of  ammonia  solution  added.  Positive  colonies  turned  pink  within  a  few   
 
minutes. 
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IDENTIFICATION OF MRSA: 
 
All   isolates  of   Staphylococcus  aureus    were  tested      for     Methicillin   
 
sensitivity   by  the  following   methods  and   the resistant  strains  (MRSA)   
 
were identified:    
       
 1.E-Test ( Oxacillin) MIC.  
       
 2.Oxacillin Resistance Screening Agar Base (ORSAB). 
       
 3.Disc Diffusion method  by using  5microgram  Oxacillin disc.   
        
 4.Disc Diffusion method  by using  30microgram  Cefoxitin  disc. 
 
The  presence  of   mecA gene   in   the   Methicillin  resistant   isolates   was  
 
confirmed  by  Polymerase Chain Reaction (PCR). 
 
PREPARATION OF INOCULUM: 
 
4 to 5 isolated colonies of  S.aureus  were taken  from  the 24 hr culture plate  
 
with the help of a sterile loop and  transferred to a test tube containing sterile  
 
peptone   water   and   incubated    for 4 hrs  at 35◦ C.    Then   the    turbidity    
 
was adjusted  to   0.5 McFarland  turbidity   standards   by   using    Vickeum   
 
chart.   This   inoculum   was   used  for  sensitivity testing by E.Test M.I.C ,  
 
ORSAB,  and     Disc  Diffusion  methods.   Known    Methicillin    sensitive   
 
(ATCC25923)   and    Methicillin  resistant  (ATCC43300)  S.aureus  strains    
 
were    used  as  controls. 
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E.TEST(EPSILOMETRY): 
 
This  is  a  gradient    diffusion  test   that   uses  a   non  porous  plastic  strip  
 
impregnated  with Oxacillin. The  strip  is calibrated  with  MIC  values  that  
 
cover   fifteen   two   fold  dilutions.  Hicomb  MIC  test  strips   supplied  by  
 
the HiMedia, Mumbai were used in this test.  Muellar  Hinton  Agar  (MHA)    
 
plates   supplemented  with  4% Nacl  were   used  for   inoculation. A sterile  
 
swab was  dipped  into  the standardized inoculum  suspension and  the swab  
 
was  rotated  with   firm  pressure   several   times  on  the  inner sides of  the  
 
tube to  remove  excess  fluid. This was  inoculated  on  the  dried  surface of  
the MHA  plate  by streaking  the  swab three  times over  the  entire  surface   
of  the  agar plate  by  rotating  the  plate 60◦ each  time  for even distribution  
 
of   the   inoculum.  Finally  the  rim    of   the   agar   was   swabbed   before   
 
replacing  the lid  of  the  Petri dish.  After  streaking  the  MH agar plate ,the  
 
agar surface was allowed to  dry  for  5 mts.  The   E-Test  strip  was  applied  
 
to the  surface of the agar with  the  help  of a  sterile forceps  with  the  MIC  
 
scale   facing  up.   This    was    incubated     at    35◦C    for   24 hrs.    After    
 
incubation   the   interpretation   of   the  result  was  done  by  observing  the   
 
MIC  where   the   zone of   inhibition  intersected   the  strip  in  the  form of   
 
an ellipse .  Isolates  showing   MIC   value    less    than   0.2  microgram/ml    
 
were   considered   as  Methicillin  sensitive  S.aureus  and  those  with  MIC     
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more  than  0.2 microgram  were  labeled  as Methicillin  Resistant  S.aureus.  
 
OXACILLIN RESISTANCE SCREENING AGAR BASE METHOD: 
 
This is a modification of MSA supplemented  with 6mg /L of  Oxacillin  and  
 
a  chromogenic  component aniline blue.The Oxacillin Resistance  Screening   
 
Agar  Base  medium  (ORSAB)   supplied  by  the    HiMedia, Mumbai   was  
 
used  in  this  test.  The  standardized   inoculum   was  streaked  on  ORSAB  
 
plate    as   done   for  E-Test   and   incubated   at   35◦C   for   24 hrs.  After  
 
incubation  the  results were interpreted. S.aureus with Methcillin  resistance    
 
showed  positive  growth  that   was   identified  by the  colour change   from   
 
original    grey  to   deep   blue. S.aureus   isolates   sensitive   to  Methicillin   
 
did  not  result  in  colour  change. 
 
DISC DIFFUSION METHOD: 
 
Kirby Bauer  technique  was  followed  for  doing  Disc  Diffusion  test.  The  
 
standardized   inoculum  was  streaked  on  MHA  plates supplemented  with  
 
4%  Nacl  as done earlier. The  Petri dish  was  allowed  to dry for 5mts with  
 
the   lid  in  place.  By  using a  sterile  forceps  30 microgram Cefoxitin  disc   
 
and 5 microgram  Oxacillin  disc  were  placed  on  the agar  surface  of  two  
 
different     MHA    plates    and    incubated   at   35◦C    for    24 hrs.   Discs   
 
supplied    by    the   HiMedia,   Mumbai   were   used  for   the   test.    After  
 
incubation  the  zone  of inhibition  was measured  by using  zone measuring  
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scale  and  interpreted  as per  the  CLSI  standards. Zone  diameter of 13mm   
 
or   more   than  13mm  was  taken  as  sensitive, 10mm or  less  than  10mm  
 
as   resistant  and  11 to 12mm   was  taken   as   intermediate   sensitive   for  
 
Oxacillin disc. Zone  diameter  of  20 mm or more   was  taken   as  sensitive  
 
and  19  mm  or   less  than  19   mm as  resistant   for  Cefoxitin disc.  These  
 
resistant  isolates  were  considered  as  MRSA. 
 
POLYMERASE CHAIN REACTION (PCR): 
 
PCR    was   done   by    the   following    Protocol   to   detect   mec A   gene     
 
in  S.aureus  isolates. 
 
DNA extraction from S.aureus isolates: 
 
1) 1.5 ml   of    overnight    S.aureus   culture    was   transferred   to  1.5   ml   
 
centrifuge  tube. 
 
2) Centrifuged   at  10000  rpm  for 5 mts;   supernatant  discarded. 
 
3)To   the   pellet    was    added    400 μl    of   Lysis   Buffer   and   40 μl   of   
 
reconstituted    Proteinase K. 
 
4) Mixed   immediately   by   inverting  and  incubated  at  70◦C  for  10 mts. 
 
5)100 μl    of   Isopropanal  is added  and  mixed  well. 
 
6)The  entire  sample  was  pipetted  into  the  Pure Fast  spin  column. 
 
7)Centrifuged  for 1mt;  discarded  the  flow-through  and the column placed   
 
back  in the same collection tube. 
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8)500 μl  of   Wash Buffer-1  was   added  to   the   Pure Fast    spin  column;  
 
Centrifuged  for  30-60  secs  and   the  flow-through  discarded 
 
9)500 μl   of    Wash Buffer-2   was   added  to  the  Pure Fast   spin  column;  
 
centrifuged  for 30-60secs  and  the flow-through  discarded;  centrifuged for  
 
additional  2mts. 
 
10) The    Pure Fast   spin  column    was   transferred   into  a   fresh   1.5 ml  
 
Micro  centrifuge  tube. 
 
11) 100 μl    of    pre-warmed   Buffer  EB   was   added    to    the   centre  of  
 
Pure Fast  spin  column  membrane;  incubated  at  room temp. for 2mts  and  
 
centrifuged  for  2mts. 
 
12)Column   discarded   and  the purified  DNA was  stored  at -20◦C 
 
13)Quality  and  Quantity of extracted  DNA was checked  by loading in 1%  
 
agarose gel  and 1 μl    of  extracted  DNA was  used for  PCR  
 
amplification. 
 
PCR procedure: 
 
Components:  (total volume-50 μl ) 
 
1.Mastermix-25 μl   
    
2. mecA Primer   (10pmoles/ μl )  F- GCAATCGCTAAAGAACTAAG 
 
     
    mecA primer –  (10pmoles/ μl )   R- GGGACCAACATAACCTAATA 
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3.Nucleus free water 22 μl  
 
4.Test samples (Genomic DNA) 1 μl   
 
Program: (total cycles run-30) 
 
Initial denaturation: 94◦ C for 3mts 
 
Denaturation: 94◦ C for 1mt 
 
Annealing: 60◦ C for 1mt 
 
Extension: 72◦ C for 1mt 
 
Final extension: 72◦ C for 5mts 
 
Agarose gel electrophoresis: 
 
1.Prepared  2%  agarose  (2gm agarose in 100 of 1 X TAE buffer and melted  
 
using micro oven) 
 
2.When  the  agarose gel  temperature  was  around  60 ◦C ,  5 μl   of  
 
Ethidium bromide was added. 
 
3.Warm agarose solution was poured slowly into the platform. 
 
4.Kept undisturbed till the agarose solidifies. 
 
5.1 X TAE  buffer was  poured  into the  submarine  gel  tank. 
 
6.The  gel  platform     was  carefully  placed  into  the  tank: the  tank  buffer  
 
level was  maintained 0.5cm  above  than  the gel. 
 
7.PCR   samples   were   loaded   after  mixing  with  gel  loading  dye  along  
 
with  10 μl of  HELINI Quick Ref 250bp  DNA ladder. 
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8.Electrophoresis    was   run at   50V    till   the    dye   reaches  three  fourth  
 
distance of  the gel.  
 
9.Gel viewed  in  UV Trans illuminator  and the bands pattern was observed. 
 
Interpretation:   The   presence    of   mecA gene   was    indicated   by   the 
 
Amplification   of   220  bp  PCR  product  from  the  clinical  isolates.    
 
   
Considering   the   PCR  as   the  standard  test,  statistics   was   applied   for  
 
Calculating Sensitivity,Specificity,Positive Predictive Value (PPV),Negative  
 
Predictive  Value(NPV) and  the P value( Chi square test)   for  each  method  
 
by  using  the  following  formulae. 
 
  
                                      True positives 
 Sensitivity=     ___________________________ 
  
                             True positives+False Negatives                       
 
  
                                    True Negatives  
Specificity=     ____________________________                                                       
                               
                             True Negatives+ False positives 
 
 
                                                            True  Positives   
Positive Predictive Value=     ____________________________ 
                            
                                                     True Positives + False Positives 
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                                                           True Negatives 
 
Negative Predictive Value=     ____________________________ 
                            
                                                     True Negatives + False Negatives 
 
                                                (O-E)2  
P value=                         ________________ 
 
                                                     E 
 
O=Observed value                       
 
E=Expected value 
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RESULTS 
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RESULTS 
 
 
                                Blood, Pus, Sputum, Throat swab  and Urine samples    
collected   from   240   cases   admitted    at  Govt. Rajaji  Hospital,  Madurai  
were  included  in  this study. This   study   included   both sexes of  all    age   
group. Out of 240 samples   68 were Blood, 70 Pus,42 Sputum, 23 Throat 
swab  and  37 were Urine  sample. Among   the    240  samples  200  showed   
growth  (83.33%)   and  40  samples (16.66%)  showed  no  growth.  Among   
the 200 isolates 134(55.83%) were Gram positive cocci, 126  (52.5%) 
Staphylococcal species and 8 (3.33%) Streptococcal species. 66  isolates 
were(27.5%) various Gram negative  bacilli.This is given in table 1. 
                                             Table No.1                                                                        
                      Specimen wise isolation of  organisms                    n=240                            
Specimen Staphylococci Streptococci    GNB  No growth  Total 
pus      44(18.3%)         16(6.66%)  10(4.16%)   70 
Blood 
43(17.9%)     
   3(1.25%)     13(5.41%)    9(3.75%)   68 
Sputum     17(7.08%)    3(1.25%)     11(4.58%)  11(4.58%)   42 
Throatswab     10(4.16%)    2(0.83%)       6(2.53%)     5(2.08%)   23 
Urine     12(5%)         20(8.32%)     5(2.08%)   37 
Total   126(52.5%)    8(3.33%)     66(27.5%)  40(16.66%)  240 
 
                                 Among    the   126    Staphylococci species   44 (18.3%)    
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were   isolated  from   Pus specimen,  43 (17.9%)   from  Blood, 17 (7.08%)  
 
from  Sputum, 10 (4.16%)  from  Throat  swab   and  12  (5%)   from   Urine   
 
samples .    From      the      above       observation     it     is     inferred     that  
 
Staphylococcal  species   were the  common isolates  from   all   the  
specimens  except  Urine  in  which  Gram negative  bacilli predominate.     
                              
 
                         Among  the 126 Staphylococcal species 103  were  (42.91%)     
 
Staphylococcus    aureus      and   23   were   (9.58%)    Coagulase   Negative  
 
Staphylococci   (CoNS).   Among   the 103  Staphylococcus aureus, 40 were   
 
(38.83%)   isolated   from  Pus specimen,  37   (35.92%)    from    Blood,  11  
 
(10.67%)  from  Sputum,  8 (7.76%)  from  Throat swab and 7 (6.79%)  were    
 
from  Urine specimen. 
 
                                             Table no.2                                                                             
                   Specimen wise  isolation of Staphylococcus aureus 
                                                                                              n=103 
 
 
 
 
 
 
 
 
 
                                                                                                                                                     
                    From  the   above   observation  it   was   found   that  S.aureus    
 
was    isolated   from   all  specimens   and   more   number   of  S.aureus    
Specimen  No. of S.aureus isolates Percentage 
Pus     40    38.83% 
Blood     37    35.92% 
Sputum     11    10.67% 
Throat swab      8      7.76% 
Urine      7      6.79% 
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were   isolated   from   Pus  samples   followed    by  Blood. 
 
                   
                   Out  of  103   S.aureus   isolates   57 (55.3%)   were   Methicillin  
 
Resistant  S.aureus   (MRSA).   Sample wise   analysis  of    MRSA  showed    
 
that  29  out  of  40  S.aureus   strains   were  detected  as  MRSA   from  Pus    
 
specimens. 19  out of  37 from  Blood,  4 out of 11 from Sputum,  2 out of  8  
 
from  Throat  swab  and  3 out of  7  S.aureus  strains  from  Urine  specimen    
 
were    identified   as   MRSA.  The  number of S.aureus   isolates   and    the    
 
percentage  of  MRSA  from  different  specimens  are given  in  the  table-3.  
 
 
                                              Table.3 
 
                           Sample wise   identification   of   MRSA                         
 
                                                                                                           
      Specimen       S.aureus                  MRSA    Percentage 
         Pus             40              29 28.15% 
         Blood             37              19 18.4% 
         Sputum             11                4 3.8% 
     Throat swab               8                2 1.94% 
         Urine               7                3 2.91% 
         Total           103              57 55.3% 
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                                 From     the     above    table    it     is     inferred     that     
 
MRSA   was   isolated   from   all   specimens   and   the    percentage   of    
 
MRSA   isolated    from   Pus   samples   (28.15%)    was   high   followed    
 
by    Blood   (18.4%),   Sputum   (3.8%),  Urine  (2.91%)   and  Throat  swab    
 
(1.94%)  Specimens.  
 
                                Analysis   of   age wise  distribution  of  MRSA  showed    
 
that   among   the    MRSA    isolates  16  (28%)   were   isolated    from   the    
 
age group     of    <1yr.  7 isolates    (12.28%)    from    the    age group      of  
 
1-15yrs,    13 (22.8%)    from   16-50 yrs    and  21    from    the     age group   
 
of   >50yrs  were  isolated.  The   age wise  distribution  of  MRSA  is  given   
 
in Table4. 
 
                                            TableNo.4 
 
                                 Agewise distribution of MRSA 
                                                                                                        n=57 
 
       Age group 
 No. of MRSA isolates         Percentage 
         <1 yr              16          28% 
           1-15                7          12.28% 
         16-50              13          22.8% 
           >50              21          36.84% 
 
 
                                     From    the   above   table    it  is   inferred  that   the 
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Percentage  of MRSA  isolated  from  the  age group of >50 yrs(36.84%)   
 
was  the  highest  followed   by <1yr  of age  (28%) showing  that  it  is  
 
common in the  extremes  of  age groups. 
 
                        Among  the  57 MRSA isolates  16 (28.06%)  were associated  
 
with risk factors. Analysis  of  MRSA  with  associated  risk  factors  showed  
 
that  10 patients (17.54%)   with   MRSA   wound   infection   had  Diabetes;   
 
3 patients (5.26%) had  Chronic Liver disease; 2 patients (3.5%)with  MRSA 
 
Urinary  infection   had  a history  of   intermittent  catheterisation;  1 patient   
 
(1.75%)  had  a   history   of   prolonged   self  medication   with   Quinolone    
 
antibiotic. The association  of MRSA with  risk  factors is  given  in Table 5. 
                                  
                                         Table 5. 
 
               Percentage  of  MRSA  associated  with  risk  factors 
                                                                                                       n=16 
Risk factors No. of MRSA Percentage of MRSA 
Diabetes Mellitus       10       17.54% 
Chronic Liver disease        3         5.26% 
Urinary catheterisation        2         3.5% 
Prolonged antibiotic intake        1         1.75% 
   
 
                           From the above observation  it  is  found  that  MRSA had  
 
 a  strong   association   with   risk  factors   such  as   Diabetes,  Chronic  
 
Liver   disease,    Urinary   catheterisation    and   Prolonged   intake   of     
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Quinolone  antibiotics. 
 
                                   All   the   103  S,aureus  isolates  were   subjected   to     
 
Methicillin      sensitivity     testing      by     various     phenotypic    methods    
 
such    as   E-Test  (Oxacillin),     Oxacillin    Resistance     Screening    Agar   
 
Base  (ORSAB) ,   Disc   diffusion   method  by  using   5 μg  Oxacillin    and 
 
30 μg   Cefoxitin  discs. By  E-Test method  54 S.aureus   strains  among 103  
 
isolates were  (52.42%) identified  as   Methicillin   resistant     (MRSA)  and    
 
49      were    Sensitive     (47.57%)     to     Methicillin      (MSSA)   ORSAB    
  
method     detected    51   MRSA    (49.51%)   from  103   S.aureus    isolates   
 
and  52   (50.48%)   were    MSSA.   By    disc    diffusion     method    using   
 
Oxacillin   disc   48   S.aureus  (46.6%)  isolates  were  identified  as  MRSA    
 
and   55  (53.39%)  as  MSSA.   By  disc  diffusion  method  using  Cefoxitin    
 
disc   56    (54.36%)     isolates   of    S.aureus    were   identified   as  MRSA    
 
and   47   (45.63%)    as  MSSA.  It   is  given   in   Table 6                     
                                          TableNo.6                                                                 
                 Detection of   MRSA  by various  methods  
                                                                                           n =103 
 
        TEST       MRSA       MSSA 
         E-Test    54(52.42%)    49(47.57%) 
        ORSAB    51(49.51%)    52(50.48%) 
     Oxacillin Disc    48(46.6%)    55(53.39%) 
     Cefoxitin Disc    56(54.36%)    47(45.63%) 
 
 
                                       From  the  above   observation   it    is   found   that   
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the  percentage   of    MRSA    detected    was    high   by  Cefoxitin   disc   
 
method   (54.36%)    followed    by    E.Test   (52.42%),   ORSAB   method  
 
(49.51%)  and  Oxacillin disc method (46.6%).            
 
                                      PCR was done for all S.aureus isolates to identify the 
presence of mecA gene and to confirm geno typically  the  MRSA isolated   
by    various   phenotypic  methods  and  the  Specificity, Sensitivity,      
Positive    Predictive    value   (PPV) ,    Negative   Predictive  Value  (NPV)   
and   Test   of    significance   for   each    method   were    calculated     as    
per    the    formulae.      Among     the     57     PCR   positive    MRSA   
strains,     Cefoxitin    disc    identified    one   isolate    as   negative  (false 
negative).  E-Test   identified   3,  ORSAB  6  and   Oxacillin    disc 9    as    
false  negatives.    Among    the   46   PCR    negative     isolates    of     
S.aureus      Cefoxitin     disc      falsely      identified    1    as    positive  
(false positive).   The    false    positives    identified    by    E-Test,   ORSAB    
and     Oxacillin     disc    were   2, 3   and  4    respectively.  This    is   given   
 
in  table 7.   The Sensitivity,  Specificity,    Positive   Predictive  Value    and    
 
Negative  Predictive  Value  are   given  in table 8.  
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                                    Table.7 
 
             Comparison of PCR with other phenotypic methods 
 
 
     Methods   True positives   False negatives False positives 
     PCR        57                     
    E-Test        54            3          2 
 Cefoxitin disc        56            1          1 
 Oxacillin disc        48            9          4 
   ORSAB        51            6          3 
 
                                  It  was   found   that  Cefoxitin  disc   method  showed  
 
only   one   false    negative   and  one  false  positive   thus  very  close  to  
 
PCR  in  identifying   true  positives. 
 
 
                                        Table 8. 
 
                 Sensitivity and Specificity of various phenotypic  tests.  
 
    TEST SENSITIVITY SPECIFICITY
 
PPV NPV 
   E-Test 94.73% 96% 96.42% 94.23% 
  ORSAB 91% 94.5% 94.44% 91.22% 
Oxacillin disc 84% 93.12% 92.30% 85.93% 
Cefoxitin disc 98.2% 97.91% 98.24% 98.27% 
                          
 
                               From   the   above  table  it   is  inferred  that  Cefoxitin  
 
disc  method   has   the   highest    sensitivity   (98.2%)    and    specificity   
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(97.91%)    and     the   PPV   and   NPV    are    98.24%     and    98.27%    
 
respectively  (Pvalue >0.05).     Oxacillin     disc    method    has   the   least   
 
sensitivity   (84%)  and  specificity   (93.12%)   with   the  PPV  and  NPV of    
 
92.30%   and   85.93%    respectively.  E-Test showed 94.73%  of sensitivity  
 
and   96%   of  specificity   with    96.42%  of  PPV  and  94.23%   of   NPV.   
 
ORSAB   method   has   91%  of   sensitivity   and   94.5%    of    specificity    
 
with    94.44%    of    PPV   and   91.22%  of  NPV.  
 
                                Among    all   these   methods   PCR   is   the   genotypic  
 
method   which   detects   the   mecA gene  in  S.aureus  isolates  resistant  to  
 
Methicillin   and    is  considered   to    be    the      gold   standard    test    for    
 
detecting   MRSA,  but  could  not  be   adopted   as  a    routine   method   of   
 
screening     MRSA     in   small   laboratories    since   it   requires     costlier      
 
and   sophisticated   equipments.  Hence   the   easily   available   phenotypic  
 
methods  were  compared   and   their   Sensitivity,  Specificity,   PPV,  NPV  
 
were   assessed   with  PCR  as  standard.  Among   the  phenotypic  methods  
 
Cefoxitin   disc   is    the    most  sensitive   and   most   economical   method    
 
which   can  detect  MRSA  almost    equal   to  PCR  and  found  to  the best  
 
method    for  routine  screening  in  small  Microbiological  laboratories.  
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            Figure 1 Number of S.aureus isolated from different specimens 
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           Figure 2  Number of MRSA detected from differernt specimens    
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                      Figure 3  Agewise distribution of MRSA 
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                      Figure 4  Percentage of Agewise distribution of MRSA 
 
28%
12.28%
22.80%
36.84% <1yr
1-15 yr
16-50 yr
>50yr
 
 
 
  -  
 
              Figure 5 Number  of MRSA detected by different methods 
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               Figure 6  Percentage of MRSA detected by various methods 
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         Figure 7 Sensitivity and Specificity of various tests 
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                  Figure8 Gel documentation of mecA gene by PCR 
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DISCUSSION 
  -  
DISCUSSION 
 
 
                     In    the    present    study,    Out  of   240    samples    processed 
55.83%   were    Gram   positive   cocci   and    27.5% were   Gram  negative   
bacilli   and  Staphylococcus  aureus was  the  commonest  (42.91%)  among 
Gram positive   cocci. S.aureus    was     isolated  as    the    prime   organism    
in    all     infections   except   urinary   tract   infection.  The   text   book   of     
Microbiology     by     C.P.Baveja[9]    also    explains   the    occurrence    of    
S.aureus     as   prime  organism   in  all  infections   and  states   that   this  is  
due   to   the   presence    of    a   number  of  enzymes  and  toxins  produced  
by S.aureus   which  may  inhibit     phagocytic  and   opsonic    mechanisms.    
Also    in    this    study,   S.aureus   was    isolated  only  in  7  patients   with    
urinary   infection   and   the   text   book   explains    that   the  less  frequent  
occurrence  of   S.aureus   in  UTI   may  be   due  to   genotypic  factors    in  
S.aureus   which  may   affect  uroepithelial   susceptibility  to  the adherence  
molecules.  
                       
                       In  this  study,  S.aureus  was  isolated  more (38.83%)  in  pus 
samples   from  Diabetic  wound   infections  occurred  as  localized  lesions. 
The  localization  is  mainly  due  to  the  unique  presence  of  coagulase   in 
S.aureus  which  has  the  capacity  of  forming  a  wall of  fibrin clot  around 
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the   lesion.  Franklin  and Lowy et al[33]  (1998 )  in   their   study   showed  
that  42%   S.aureus    were    isolated    in   pus    samples    collected    from   
localized    lesions    in    Diabetics   which    is  in   concordance    with   the   
present  study. They    explained  that   the    adherence   of   Staphylococcus   
allows    only  mucosal  colonization  and  hence  localized  lesions. 
                          
                          The  present  study  showed   55.3%   MRSA .      Pulimood   
and    Lalitha[102]     (1993)     in      their    study    showed    24%     MRSA,   
Rajaduraipandi   et al[103]     (2001)     documented   37.9%    MRSA   and     
Anuparba    et al[7]  (2006)    documented   54.8%.   Van  Beikum  et al[125]  
explained  that   the   incidence   of   MRSA  was   steadily increasing   since 
it’s emergence in 1960s. The increased  trend  may  be  due  to   the   adverse  
use   of   antibiotics   resulting   in  faulty    genetic    background    or    poor  
infection   control  practices   in   the environment. 
                            
                            In this study,   28.15%  of  MRSA  was  isolated  from  pus 
samples   and     this   is    supported    by    the    study   of   Trivete.SL and  
Kirkland.KB[122] (1999)  which  showed  30%  MRSA  in  pus  samples.The  
increased   incidence  of MRSA   in   wound   infection  may  be  due  to  the   
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production  of   Panton Valentine  Leucocidin  (PVL)  by  MRSA  which  is  
known to be associated with  tissue  necrosis. 
                        In   the   present  study , it   was   proved    that   MRSA   was  
commonly   present  in  the   extremes   of    age.  An  incidence   36.84%  of 
MRSA  was  present  in  the age  group  above   50 yrs   and  an incidence of 
28%  was  present  in  the  infants  especially  in   Bacteremia. Similar  study  
by  Bayer et al [10](2005)   and    Mary  Healy et al[83]   (2004)    showed   an  
incidence of   30%  MRSA  in  infants  with   Bacteremia.   More   incidence   
in   higher  age group   may   be   due   to   immuno suppression   caused   by 
various  factors  like   Diabetes  Mellitus,  Chronic Hepatitis  and   Anaemia.   
Similarly,  in  infants    there    may   be    poor    development   of    immune  
system   due  to various  causes. 
                         In  this  study,  it  was  also  proved   that  MRSA   infections 
always associated   with   risk   factors.  17.5%   MRSA   wound    infections   
were   Diabetics , 5.35%  had  Chronic Hepatitis,4.2% Urinary tract infection 
were  with  catheters,  0.5%  MRSA  had  self   medication   with   quinolone 
antibiotics. Similar  study   by  Bayer et al[10] (2005)  documented   Diabetes  
Mellitus   and  Chronic Hepatitis as  risk  factors  in  MRSA infection.Ulrich 
Seybold[123] (2006)   described    frequent    catheterisation   as   one   of   the   
risk  factors   for  acquiring  MRSA   urinary   infection .Tacconelle et al[118] 
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(2008)  proved    the    association   of   prolonged   exposure   to   quinolone   
antibiotic  with   MRSA  infection.  The   occurrence  of   MRSA  in  various  
infections    with     associated     risk   factors   may   be   due   to    acquired  
chemotactic  defects  or  opsonic  defects. 
 
                       The    early    and    accurate    determination    of   Methicillin 
resistance   is  of   key  importance   in   the  prognosis  of  infections  caused 
by  S.aureus.  Although   many   phenotypic  methods   of   detection  of  this 
resistance  have  been  developed,  they  often  show   insufficient sensitivity 
and   specificity   to  ensure   appropriate  treatment  of  the  MRSA  infected 
patients. The  sensitivity  and  specificity  of  these  methods  vary depending 
on  the   patients  carrying  them,  environmental factors  and  the  techniques 
used.   In   this   study   various    phenotypic   methods    like    E-Test     for   
Oxacillin,     ORSAB    with    6  micrograms   per   ml   of Oxacillin,     Disc   
diffusion    methods    using   5 μg    Oxacillin    and   30 μg   Cefoxitin   discs  
were   compared    and   found   that   among   the  phenotypic methods,  disc 
diffusion    by   Cefoxitin    disc   showed    98.2%   sensitivity   and  97.91% 
specificity     with    a   positive    predictive   value   of    98.24%,    negative 
predictive   value     of     98.27%      with     p value  >0.05.  Among    the   4 
methods,  Oxacillin  disc  diffusion  showed   the  lowest   sensitivity  (84%),  
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specificity  (93.1%),   positive    predictive   value  (92.3%)     and    negative   
predictive   value  (85.93%).  This  is  supported  by  the  studies  of   Stokes  
et al [116] (2006)    who    documented     99.1%     sensitivity     and     98.1%   
specificity   by   Cefoxitin  method  in  the  detection  of  MRSA .   Similarly    
Annifelten  et al[5]    (2002),     David  Velasco  et al[25    (1997),    Swenson   
et al[117]   (2001)   showed   100%    sensitivity   and   100%    specificity   by   
Cefoxitin    disc     diffusion     method.    Cavasinni     and   Wenger    et al 
(1999)[17]   showed   100%   specificity  and  sensitivity,  Negative  predictive   
value  100%    and     Positive   predictive value    98%    by   Cefoxitin   disc  
method.    They      also     showed     only     89%    specificity     and     84%  
sensitivity   by   Oxacillin  disc  method  which  is similar  to  the  finding  of   
the    present   study.   Detection   of    MRSA   by Cefoxitin  based  methods  
will  not  be  affected  by  temperature  variations between  35◦ C  and  37◦ C   
but    Oxacillin     method   will   be    affected   by   temperature    variations  
especially   if  it  is  increased   above  35◦C.  Similar environmental   factors   
and    host   factors   decrease   the     sensitivity    and   specificity   of   other 
agar  dilution   methods  and   E-Test. 
                             The   comparison     of    PCR    as    gold  standard     with   
the   other    phenotypic   methods    showed    that    56    out    of   57 mecA  
positives  were   true   positives by  Cefoxitin  disc  method,  proving  that  it  
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is   close   to   the    detection  of   mecA  gene   in  MRSA  by  PCR. Thus  it  
was   proved   that  Cefoxitin  disc method   can  be   used  as  an  alternative  
to   PCR    for   detection   of    MRSA   in     resource     constraint   settings.  
Anila et al[4]   (2010)     and    Skove et al   (2006)[112]    in     their      studies      
proved     that     Cefoxitin    method     was    close   to    PCR   in   detecting    
MRSA,      thus      supporting       the       present       study.       Cefoxitin,   a   
Cephomycin    is   a   more    potent    inducer   of    the     mecA    regulatory    
system.     Hence      the      results      of      Cefoxitin    disc   diffusion   tests    
correlate     better     with    the      presence     of    mecA   than   do  the  disc  
diffusion  tests  by    other   discs like  Oxacillin. 
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SUMMARY 
  -  
SUMMARY 
                          
 
 The    study  showed   55.83%   Gram positive   infections   among   various 
 
 specimens   and   out   of     which   42.91%    were   Staphylococcus aureus.  
 
Among   the   Staphylococcus aureus  isolates  55.3%  were   MRSA. 
 
 
28.15%  MRSA  were  isolated  from  pus  samples  collected from localized 
lesions  mostly from Diabetics. 
 
MRSA  was  common  in  the  extremes  of  age group. 36.84%  were  found 
in   the   age group   above   50 years   and  28%    were   found   among   the  
infants,    with   septicemia. 
 
MRSA   was   common   in   patients   with    associated    risk   factors   like 
Diabetes  Mellitus   (17.54%),       Chronic  Hepatitis     (5.35%),       Urinary 
catheterisation (3.5%)   and   prolonged antibiotic  intake (1.75%).  
 
Phenotypic   methods   for   identification  of   MRSA  were  compared   and  
found   that  Cefoxitin  disc  diffusion   method    detected  more  number  of   
MRSA  ( 54.36%)  than   other   methods   like   E-Test  (52.42%),   ORSAB 
(49.51%) and  Disc  diffusion  method   with  Oxacillin(46.6%).   
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CONCLUSION 
  -  
CONCLUSION 
 
 
Staphylococcus  aureus   is   responsible   for  a  broad    range   of   Hospital  
 
infections  at  GRH,  Madurai. Methicillin  resistance among Staphylococcus  
 
aureus   has   steadily   increased   especially   among   patients   admitted  in  
 
hospitals   with  extremes of  age, localized  wound  infections and infections  
 
associated  with   risk   factors    like   Diabetes Mellitus,  Chronic  Hepatitis,  
 
catheterisation   and  prolonged  antibiotic  administration. 
 
As  MRSA  infection  is difficult to treat , early  diagnosis  and  management 
is necessary to  reduce  the  morbidity  and  mortality. 
This  study   was   focused    on    finding out   of  a  simple,   economic   and  
more  accessible   method   with   high  sensitivity  and specificity to identify 
MRSA                                                                                                                             
 
Various  phenotypic   methods  were compared  with  PCR  as gold  standard  
and   found    that    Cefoxitin   disc   method    showed    98.2%   sensitivity,  
97.91%  specificity   and  it  is  closer  to  PCR. 
 
Cefoxitin  disc  diffusion  method   was   proved   to   be   the   simple, easily 
available,  economical  method  giving  the  results  almost  similar  to PCR. 
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Thus  for  any  small  Microbiological  laboratory  with  resource constraints, 
Cefoxitin  disc  diffusion  method  can  be   recommended  as  an  alternative   
to  PCR  for  the  early  and  prompt  diagnosis  of  MRSA. 
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ANNEXURE-1 PREPARATION OF GRAM STAIN 
GRAM STAIN REAGENTS 
1.Methyl violet   Primary stain 
      Methyl violet 10g 
      95% ethyl alcohol  100ml 
      Distilled water  1L 
2.Gram’s Iodine  Mordant 
       Iodine 10g 
       Potassium Iodide 20g 
       Distilled water 1L 
3.Acetone  Decolouriser 
4.Dil. Carbol Fuchsin   Counter stain 
          Basic fuchsin 0.3g 
          95% Ethyl alcohol  10ml 
          Phenol crystals, melted 5ml 
          Distilled water  95ml 
Dissolve fuchsin in alcohol.Add the 5% phenol solution.Let it stand 
overnight.Filter through coarse filter paper. 
 
 
  -  
ANNEXURE  2  PREPARATION  OF  MEDIA 
PREPARATION OF BLOOD AGAR PLATE: 
To prepare 500 ml of molten agar  in 1L flask. 
1.Add  500ml  of  agar  into  500ml  of  water. Heat to dissolve. 
2.Autoclave at 121◦ C for 20 mns. Cool to 50◦ C. 
3.Add 5%  sterile,    defibrinated    sheep blood   (25  ml  of   sheep blood   is 
added to 500ml of molten agar) 
4.Dispense 15-20ml into Petri dishes. To remove the bubbles,  media may be 
flamed.  Allow to  solidify, dry out. Place  the   plates  in  a  plastic  bag  and 
store at 4◦ C. 
PREPARATION OF OXACILLIN REISTANCE SCREENING  AGAR 
BASE MEDIUM 
To prepare 500ml of ORSAB medium 
1.  Rehydrate    the     contents    of   vial   containing   Oxacillin   Resistance 
Selective  Supplement  with  2ml  of  sterile  distilled  water  aseptically. 
2.  Mix   well   and   aseptically   add     it   to   500ml   sterile,    molten   and  
cooled (45-50◦ C) Oxacillin  Resistance  Screening  Agar  Base. 
3.  Mix  it  well  and  dispense  15-20ml  into  Petri  dishes. 
 
 
  -  
ANNEXURE-3 
                                       Case  Investigation  Form 
                                                                                Date: 
Patient’s Name:                                                                  Patient’s I.D.No. 
                                                                                            Age/Sex: 
Parent / Spouse Name: 
Address: 
Date of onset of illness: 
Date of Hospitalisation: 
Clinical signs and symptoms( with duration): 
Treatment History: 
Associated conditions: 
Specimen details: 
Name of specimen Date of collection Investigation required 
   
   
Details of the sender: 
Signature: 
Name of sender:                                                     Telephone no. 
  -  
ANNEXURE-4 
                                         Laboratory Form 
                                                                      Date: 
Patient’s Name:                                                       Patient ‘s I.D No. 
Age/Sex:                                                                  Laboratory Reference No. 
Specimen details: 
 
Type of 
Specimen 
Date of 
collection 
Date of 
receipt in 
lab 
Type of 
test 
Remarks if 
any 
Result 
      
      
      
      
 
Interpretation: 
Details of Investigator: 
Name:                                                                                    Signature 
 
  -  
Ref.No.15806 / E4 / 3 / 2010    Govt.Rajaji Hospital, Madurai - 20, 
       Dated : 05.01.2011. 
 
 Sub : Establishment - Government Rajaji Hospital, Madurai-20 - Minutes of the 
Ethical Committee meeting held on 9.12.2010 - Regarding. 
      ----------------- 
 
 Minutes of the Ethical committee meeting held at 12.00 Noon on 09.12.2010 of 
the Medical Superintendent’s Chamber, Govt. Rajaji Hospital, Madurai. The following 
members of the committee were present and the following points were decided in the 
meeting. 
 
1. Dr.S.M.Sivakumar, Ms, 
Govt. Rajaji Hospital, Madurai. 
Medical Superintendent Convenor 
2. Dr.N.Vijayasankaran, M.Ch(Uro) Sr.Consultant Urologist, 
Madurai Kidney Centre, 
Sivagangai Raod, Madurai 
Chairman 
3. Dr.T.Meena, MD Prof of Physiology Madurai 
Medical College. 
Member 
4. Dr.Moses K.Daniel, MD Professor of Medicine, 
Madurai Medical College. 
Member 
5. Dr.S.S.Dilsath, MD (O & G) Prof. of Surg. Oncology, 
Mdurai Medical College. 
Member 
6. Dr.B.K.C.Mohan Prasad, M.Ch 
(Surg.Oncology) 
Prof. of Surg. Oncology, 
Madurai Medical College. 
Member Secy 
7. Shri.S.Sivakumar, M.A. (Social) 
M.Phil 
Sociologist, Plot No.51, F.F., 
K.K.Nagar, Madurai-20. 
Member 
 
The following Projects are Approved : 
Sl.No. Name of the 
Applicant 
Course Name of the Project Remarks 
1. Dr.Geetha 
Ramachandran 
Scientist “C”  
(Principal Investigator) 
Dept. of Clinical 
Biochemistry 
Pharmacology 
Pharmacokinetics of 
anti-tuberculosis drugs 
in children Impact of 
age, nutritional status 
and HIV infection 
Approved 
2. Dr.K.Nalini Lecturer in Microbiology 
Dept., Ayya Nadar 
Janaki Ammal College, 
(Autonomous) Sivakasi 
Molecular Analaysis of 
Multidrug Resistant 
Gene From Bacterial 
Isolates Associated with 
Urinary Tract Infections 
Approved 
  -  
 
3. Dr.W.Isabel P.G.Professor &Head, 
PG & Research 
Department of Zoology, 
Lady Doak College, 
Madurai. 
A study on the level of 
Biochemical Profile, 
certain elements & PKD 
genes Polymorphism in 
patients with Polycystic 
Kidney Disease in 
Madurai 
Approved 
4. Dr.T.Rajendran PG student in MD 
(Microbiology) Institute 
of Microbiology, MMC, 
Madurai 
Comparison of the 
Efficacy of Disc 
Diffusion method with 
other methods - E Test, 
Oxacillin Resistance, 
screening Agar in 
detection of Methicillin 
Resistance Staph, aureus   
Approved 
5. Dr.D.Saradha PG student in MD 
(Micro biology) Institute 
of Microbiology, MMC, 
Madurai 
Aetiological Agents 
involved in Microbial 
Keratitis 
Approved 
6. Mr.Praveen.J. II Year M.Sc. Nursing 
Student, CSI Jeyaraj 
Annapackiam College of 
Nursing, Pasumalai, 
Madurrai 
Seeking permission to 
conduct the research 
study - A study to assess 
the effectiveness of 
chewing gum on early 
bowel movement after 
major abdominal 
surgeries in GRH, 
Madurai 
Approved 
7. Dr.A.Mahalakshmi Research Associate, 
C/o.Dr.P.Gunasekaran, 
Dept. of Genetics, 
School of Biological 
Sciences, MKU, Madurai
Developing a reference 
set of microbial genome 
sequence and 
preliminary 
characterization of the 
human microbiome in 
tuberculosis 
Approved 
8. Dr.Leon Vengazhyil 
Alexandar. 
PG Student in MS (G.S) 
I Surgical Unit, GRH & 
MMC, Madurai 
Incidence of 
Hypocalcaemia 
following Near Total 
Thyroidectomy and total 
Thyroidectomy 
Approved 
9. Dr.S.Victror 
Devasirvadam 
Associate Professor, 
Dept. of Medical and 
Surgical Nursing, Sara 
Nurshing College, 
Dharapuram, Erode Dist. 
Permission to do Ph.D., 
research study data 
collection 
Approved 
  -  
10. Dr.K.Rajendran, PG in Pharmacology, 
Institute of 
Pharmacology, MMC, 
Madurai 
Circadian Rhythm 
Related 
Myelosupperssion 
Varriation resulting 
from standard 
Methotrexate, Doxo 
rubicin based cancer 
chemotheraphy 
Regimen. 
Approved 
11. Dr.Dhanya.S PG Student in MS (GS) 
III Surgical Unit, GRH & 
MMC Madurai 
A clinical study of 
Abdominal Wound 
Dehiscence 
Approved 
12. Dr.N.Jayaprakash PG in MS (GS) III 
Surgical Unit, MMC & 
GRH Madurai 
Incidence and Clinical 
Presentation & 
Management of 
Abdominal Tuberculosis 
in GRH, Madurai 
Approved 
13. Dr.K.Dilip Kumar PG Student in MS (GS) 
V Surgical Unit, GRH & 
MMC Madurai 
Comparative Study 
between post operative 
outcomes of 
transabdominal 
preperitoneal repair Vs 
totally Extraperitoneal 
repair for inguinal 
Hernia Repair 
Approved 
14. Dr.S.Rameshkumar Scientist B (Medical) 
Tuberculosis Research 
Centre, (iCMR), Word 
62, GRH, Madurai 
Comparative 
Pharmacokinetics of 
rifampicin during daily 
and intermittent dosing 
in HIV-TB Patients 
Approved 
15. Dr.R.G.Chandramouli PG Student in MS (GS) I 
Surgical Unit, GRH & 
MMC, MDU. 
An Analylical Study of 
Liver Abscess 
Approved 
16. Dr.K.Ravikumar PG Student in MS (GS) 
II Surgical Unit, GRH & 
MMC, Madurai 
A Comparative Study of 
Rubber band ligation 
and Sclerotherapy in 
patients with second 
degree hemorrhoids 
Approved 
17. Dr.A.Jagadishsingh PG Student in MS (GS) 
II Surgical Unit, GRH & 
MMC, Madurai 
Role of Surgery in 
Carcinoma Oesophagus 
- Current status - An 
Experience at MMC 
During 2010-2011. 
Approved 
  -  
 
18. Dr.S. 
Thirumalaikannan 
PG Student in MS (GS) I 
surgical Unit, GRH & 
MMC, Madurai 
Various Clinical 
Presentations and 
Treatment Modalities of 
CA RECTUM 
Approved 
19. B.Amitha Patel, 
S.Sudha Priya 
II M.Sc Biotechnology, 
LDC, Madurai 
A Study on Prevalence 
of Cervical Cancer and 
Ethiology Through HPV 
Infection Using 
Karyotyping and PCR 
Investigation 
Approved 
20. Prof.C. 
Balasubramanian, 
MS, MCH 
Prof & Head of the 
Dept., Dept of Plastic 
Surgery, MMC, & GRH 
Madurai. 
Ethical Committee 
Project Work approval 
Approved 
21. Dr.R.Mohan PG Student in MS (GS) 
IV Surgical Unit, 
GRH&MMC Madurai. 
Study About the 
incidence of Common 
Bile Duct Stones in 
GRH 
Approved 
22. Dr.D.Prince Peter 
Dhas 
MS PG in 
Othorhinolaryngology, 
Dept. of ENT MMC, 
Madurai 
Comprehensive study on 
Rhinoplasty 
Approved 
23. Dr.S.Shankareswari PG Student, Institute of 
Pharmacology, MMC 
Madurai 
Study on effect of 
Febuxostat on 
Hyperuricemia in 
Patients with mild to 
moderate renal 
impairment and 
Hyperuricemia 
Approved 
24. Dr.C.Saravanakumar PG Student, Institute 
Pharmacology, MMC 
Madurai 
A Prospective and 
comparative clinical 
study of Theophyline 
and  acebrophylline in 
patient with bronchial 
asthma 
Approved 
25. Dr.Vinay Kumar 
Guruath 
PG Student, General 
Surgery, MMC Madurai 
A clinical Study on 
Typhiod lleal, 
Perforation 
Approved 
26. Dr.A.Ramesh PG Student, General 
Surgery, MMC Madurai. 
A Study of Incisional 
Hernia Incidence And 
Risk Factors, 
Approved 
  -  
 
27. Dr. Aswin.K. PG Student, General 
Surgery, MMC Madurai 
A Clinical Study in 
Gastric Outlet 
Obstruction 
Approved 
28 Dr.Kamaraj.R. PG Student, General 
Surgery, MMC Madurai 
A study of association 
between BPH and 
Inguinal Hernia 
Approved 
29. Dr.Anoop.P.S. M.S. P.G in E.N.T., 
MMC, Madurai 
Endoscopic Findings 
and Radiological 
Apperance in Chronic 
Rhinosinsusitis  
Approved 
30. Dr.G.Selvarani Assistant Professor, 
Cardiology, MMC, 
Madurai 
A Study of Metabolic 
Syndrome, Obesity And 
Co-Morbidies in a 
Special Population 
(Staff Nuses) 
Approved 
31. Dr.R.Chellapandian PG Student, General 
Surgery, MMC Madurai 
Case Study of 
Abdominal Surgical Site 
Infection 
Approved 
32. N.Jessie Metilda Associate Professor, CSI 
Jeyaraj Annapackiam 
College of Nursing, 
Pasumalai, Madurai 
A Study of asses the 
determinants and 
practice of permanent 
family planning method 
among eligible couples 
at Madurai District 
Approved 
 
 
 
 
To : The Applicants 
 
A   STUDY   ON   COMPARISON  OF   VARIOUS    METHODS    OF   DETECTION      
             OF  METHICILLIN  RESISTANT  STAPHYLOCOCCUS  AUREUS                 
  
                                                     Abstract 
 
Introduction :   Methicillin   Resistant   Staphylococcus   aureus  (MRSA)   is   emerging  
as   one  of  the  Nosocomial  pathogens  causing   wide  range  of   infections    involving  
the  Blood stream, Skin and Soft tissues,  Bones and Joints  and  Central Nervous System. 
Since   it   is   difficult   to   treat   MRSA    infections,   early  and   accurate   diagnosis is  
necessary  to reduce morbidity  and  mortality. 
 
Aim:  The   study   was  aimed   to  find out   the  prevalence  of  MRSA  in  Government 
Rajaji   Hospital  (GRH),   Madurai   and    also   to   evaluate   the   various   methods   of  
identification   of    MRSA  and  to  find  out   the   most   sensitive   and  easily  available  
method    that    can   be   recommended   for   routine    use    in    small   Microbiological 
laboratories. 
 
Materials and Methods:   Becteriological  culture  was  done  to  isolate Staphylococcus 
aureus    from   various   samples   like  Pus,  Blood,  Sputum,  Throat   swab   and   Urine 
collected  from  patients  who  were  admitted at  GRH, Madurai.  S.aureus was identified 
by  standard Bacteriological  techniques.All S.aureus iaolates were tested for  Methicillin 
sensitivity  by  phenotypic methods such as E-Test, Oxacillin Resistance  Screening Agar 
Base(ORSAB)  and   Disc diffusion  methods   by  using   Oxacillin  and  Cefoxitin discs. 
PCR  was  done  to confirm the presence of mecA gene in Methicillin resistant strains.All 
phenotypic methods were compared  with  PCR as standard  to find out the most sensitive 
method in identifying MRSA. 
 
Results:   Out of  240 samples, 200 showed positive growth.Among the 200 isolates 103 
were   S.aureus   out   of    which   57  were  identified  as  MRSA   by  PCR.  Among  the  
phenotypic   methods ,  Cefoxitin   identified   56   MRSA   with   98.2%   sensitivity  and  
97.91% specificity in comparison with  PCR. 
  -  
Conclusion:  In  the   present   study   the  prevalence of   MRSA  in  GRH, Madurai  was  
55.3%   and  the  most  sensitive   and  easily available  method  to  identify   MRSA  was 
Cefoxitin disc method. Hence,  Cefoxitin  disc can be recommended for routine screening 
of MRSA in small Microbiological laboratories. 
Key words:    MRSA,  E-Test,  ORSAB, Oxacllin, Cefoxitin,  Disc diffusion,  PCR 
   
 
